cluster path 01100111100011

1,980 words, 14,847 tokens freq alpha suffix

Words in frequency order

1	f	6,657
2	δ	1,115
3	ln	742
4	f2	316
5	τ	307
6	in-process	213
7	ω	141
8	π	133
9	f4	88
10	mef	74
11	φ	66
12	δg	62
13	∆	58
14	1+2	53
15	fj	50
16	neu	47
17	mim	46
18	2n	45
19	bausch	43
20	v0	40
21	18:3	39
22	coo	38
23	f-	37
24	pre-op	37
25	t-c	37
26	22:6	35
27	1-1	34
28	d+	31
29	g3p	28
30	x1	28
31	x3	28
32	20:5	27
33	\|	27
34	λmax	26
35	cs3	25
36	3cl	24
37	cl1	24
38	phet	24
39	sensodyne	24
40	20:4	23
41	f6	23
42	δr	23
43	sbf6	22
44	spti	21
45	π*	21
46	c22:6	20
47	19/22	19
48	ψ	19
49	test-a	18
50	p11	17
51	rebec	16
52	-no	15
53	//	15
54	n6	15
55	3/45	14
56	neupogen	14
57	pronamel	14
58	wth	14
59	10/16	13
60	4,7	13
61	4/21	13
62	carbamoyl	13
63	placebo/placebo	13
64	qvar	13
65	xeu	13
66	×3	13
67	benz	12
68	p-c	12
69	test-b	12
70	t₀	12
71	σ*	12
72	5/32	11
73	c20:5	11
74	cl3	11
75	coleus	11
76	csf-p	11
77	deltae	11
78	elutes	11
79	j2	11
80	qam	11
81	rvesp	11
82	sens	11
83	vbus	11
84	evista	10
85	f₂	10
86	gd2	10
87	high-sfa	10
88	och3	10
89	pax	10
90	ph-ponv	10
91	sc3n	10
92	ν1	10
93	ν3	10
94	2+3	9
95	22:5	9
96	3/39	9
97	4/32	9
98	9/31	9
99	dmap	9
100	dpcpx	9
101	essm	9
102	g-cem	9
103	hfnu	9
104	humapen	9
105	isosurvival	9
106	k2hpo4	9
107	me2	9
108	pim1	9
109	regel	9
110	stimtg	9
111	trak	9
112	∆g	9
113	0.79-0.98	8
114	0/17	8
115	1.04-1.16	8
116	11/50	8
117	15/40	8
118	32/37	8
119	cisd	8
120	extem	8
121	ndpa-fe₃o₄	8
122	qlq-h	8
123	salen	8
124	simde	8
125	-arginine	7
126	0.38-0.66	7
127	3/28	7
128	acr-n	7
129	b2o3	7
130	diane	7
131	dione	7
132	e'/	7
133	f-2	7
134	gt1	7
135	honorarium	7
136	k0	7
137	mollosil	7
138	pcdf	7
139	sbst	7
140	yl	7
141	0.72-1.28	6
142	15/32	6
143	16/42	6
144	19/37	6
145	22/27	6
146	31/36	6
147	31/46	6
148	39/56	6
149	4/28	6
150	4/39	6
151	cusimano	6
152	dyne/cm	6
153	fact-h	6
154	fluarix	6
155	haritaki	6
156	hemagglutinin-neuraminidase	6
157	ipdasi	6
158	pentyl	6
159	proto	6
160	rpap	6
161	sulfinyl	6
162	sβ	6
163	xdy	6
164	yttrium-scandium-gallium-garnet	6
165	δ6mwt	6
166	-0.512	5
167	-log	5
168	1+exp	5
169	19/39	5
170	22/39	5
171	4/58	5
172	4/89	5
173	75/76	5
174	agcl	5
175	alvr	5
176	chapso	5
177	cofe₂o₄	5
178	crs/kg	5
179	d=0.55	5
180	drug/drug	5
181	dxz	5
182	ex65	5
183	extrastep	5
184	ferrocenyl	5
185	fs1	5
186	g6p	5
187	gdsand	5
188	ge10	5
189	gmfcs-e	5
190	hewitt	5
191	ibα	5
192	immunofortis	5
193	life-h	5
194	m3o-bc59	5
195	mdfr	5
196	pd-negative	5
197	pharmacometrics	5
198	phosphinoyl	5
199	pr2	5
200	rr=1.27	5
201	rv/	5
202	saramuro	5
203	sestamibi-1	5
204	si-prp	5
205	thiq	5
206	vmu	5
207	wca6h	5
208	xtb	5
209	δn	5
210	0.54-0.97	4
211	0.84-0.90	4
212	0.85-1.15	4
213	0.9-2.9	4
214	0.95-1.43	4
215	0.98-1.81	4
216	1.5-5.6	4
217	1/73	4
218	14/64	4
219	15/65	4
220	16/87	4
221	2/94	4
222	20:3	4
223	3-methyl-4-	4
224	4-41	4
225	51/61	4
226	6-54	4
227	8-iso-pgf2	4
228	8/52	4
229	amalaki	4
230	bmd-dr	4
231	cd+	4
232	cd40lg	4
233	cfu-c	4
234	circumferential-longitudinal	4
235	clno	4
236	cobamamide	4
237	consort-spi	4
238	deci	4
239	diarylpropionitrile	4
240	diphenylmethyl	4
241	dly	4
242	do3a	4
243	ec1	4
244	ethyl-esters	4
245	evpm	4
246	fp100	4
247	g-jstomy	4
248	glrav-1	4
249	greuter	4
250	hdpd	4
251	hotm	4
252	hr=0.32	4
253	hr=0.66	4
254	hydroxy-α-sanshool	4
255	iief-q9	4
256	improvac®	4
257	in10	4
258	isobenzofuran-1	4
259	jmn–mn	4
260	kbagd	4
261	lmw-ha	4
262	lns-p	4
263	mb5	4
264	neisvac-c	4
265	ntrtis	4
266	ons1200	4
267	pao2/pao2	4
268	pb12	4
269	pbu3	4
270	ptio	4
271	rr=0.40	4
272	rr=2.8	4
273	rt7ss	4
274	simplestep	4
275	tr/pr	4
276	zolinza	4
277	±0.01	4
278	αlac	4
279	₅₀	4
280	0.16-0.62	3
281	0.21-0.55	3
282	0.29-0.58	3
283	0.38-0.71	3
284	0.39-0.80	3
285	0.50-1.45	3
286	0.65-0.77	3
287	0.71-1.17	3
288	0/73	3
289	0/82	3
290	1.00-1.58	3
291	1.10-1.51	3
292	1.12-1.67	3
293	1.201	3
294	1.4-3.6	3
295	1/39	3
296	1/41	3
297	1/53	3
298	10/70	3
299	13/34	3
300	17syn	3
301	2-34	3
302	2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine	3
303	22/42	3
304	23/37	3
305	23/78	3
306	25/66	3
307	29/69	3
308	2ehrz	3
309	3'-igh	3
310	3,4-dhpea-eda	3
311	3.2h	3
312	3.532	3
313	3/56	3
314	31/29	3
315	33/47	3
316	34/48	3
317	35/48	3
318	4/63	3
319	4·72	3
320	5/154	3
321	57/63	3
322	7-eth-d	3
323	7/118	3
324	7/83	3
325	8/119	3
326	8/153	3
327	89.61	3
328	alpha-bab	3
329	anhedonia-asociality	3
330	auc0-12hr	3
331	b2→b19	3
332	baso	3
333	bazyluk	3
334	bi-arg/au	3
335	bibhitaki	3
336	breadsticks	3
337	c-bat	3
338	c10m	3
339	c6h5cho	3
340	cassagnau	3
341	caucasian/white	3
342	cichlidae	3
343	control-placebo	3
344	courneya	3
345	d9901	3
346	d=0.11	3
347	denzir	3
348	des-31,32-pi	3
349	diškus	3
350	dyz	3
351	enterobacteriales	3
352	eyewash	3
353	f3/2	3
354	folate-5	3
355	gr125743	3
356	hcnt	3
357	hif-1β	3
358	hr=0.36	3
359	hr=1.28	3
360	imal	3
361	j/k	3
362	jmv	3
363	kinact	3
364	kt-cfp	3
365	la/sa	3
366	led-1500	3
367	lehtinen	3
368	lgi-lgl	3
369	lv-sd12-l	3
370	mcdas	3
371	meiser	3
372	mnse	3
373	n-bu4n	3
374	n=c	3
375	ni-sar	3
376	nolac	3
377	non-abc	3
378	n¹	3
379	ofirmev	3
380	orf5	3
381	pdrug	3
382	pedop-au	3
383	py2	3
384	rv-rag	3
385	rv-strain	3
386	rvfw-s	3
387	rvsrs	3
388	sm1a	3
389	smd=0.45	3
390	smz/tmp	3
391	sn10	3
392	soyang	3
393	subfragment-1	3
394	tacd	3
395	tae-yang	3
396	tdelay	3
397	top-8	3
398	trimethacrylate	3
399	trois	3
400	tvb	3
401	v90i	3
402	vectibix	3
403	vos	3
404	x16	3
405	x2-	3
406	xami	3
407	yvo	3
408	±0.23	3
409	∆ψ	3
410	+2.6°	2
411	-0.307	2
412	-0·50	2
413	-2.583	2
414	-2.890	2
415	-aspartate	2
416	-factor	2
417	-intention-to-treat	2
418	//clinicaltrials.gov/ct2/show/nct00169312	2
419	//clinicaltrials.gov/ct2/show/nct00721786	2
420	//clinicaltrials.gov/ct2/show/nct00992264	2
421	//clinicaltrials.gov/ct2/show/nct01469689	2
422	//www.clinicaltrials.gov/ct2/show/nct01236209	2
423	//www.controlled-trials.com/isrctn35739639	2
424	0-8.0	2
425	0.00-0.18	2
426	0.070-0.079	2
427	0.09-0.29	2
428	0.09-0.99	2
429	0.10-0.60	2
430	0.23-0.45	2
431	0.34-0.72	2
432	0.36-0.61	2
433	0.36-0.62	2
434	0.41-1.91	2
435	0.51-1.08	2
436	0.55-0.65	2
437	0.55-1.27	2
438	0.58-1.14	2
439	0.59-1.23	2
440	0.59-1.52	2
441	0.65-1.15	2
442	0.82-3.18	2
443	0.88-1.98	2
444	0.89-1.38	2
445	1,72	2
446	1-223	2
447	1.00-1.34	2
448	1.01-2.49	2
449	1.01-2.73	2
450	1.03-3.33	2
451	1.05-1.21	2
452	1.05-1.71	2
453	1.1-7.8	2
454	1.16-	2
455	1.18-1.82	2
456	1.26-3.16	2
457	1.3-10.9	2
458	1.3-30.7	2
459	1.3-6.8	2
460	1.35-1.61	2
461	1.49-fold	2
462	1.53-2.39	2
463	1.611	2
464	1.78-4.27	2
465	1.99/2	2
466	10/181	2
467	100/172	2
468	106‑126	2
469	11.1-21.0	2
470	11/47	2
471	111.24	2
472	12/178	2
473	13/74	2
474	14.0±3.0	2
475	15-47	2
476	17/118	2
477	173491	2
478	18/81	2
479	1966-97	2
480	199/242	2
481	1·84	2
482	2-amino-2-	2
483	2.246	2
484	2.6-10.6	2
485	2/135	2
486	2/85	2
487	2006-001795-20	2
488	207.6	2
489	22/151	2
490	22/164	2
491	22/66	2
492	23/70	2
493	243.9	2
494	252/274	2
495	256.2	2
496	28/56	2
497	2·44	2
498	3'ψβ	2
499	3,4-dimethyl-5,5-dioxidopyrazolo	2
500	3-substituent	2
501	3.1-8.7	2
502	3.2-4.9	2
503	3.3-8.8	2
504	3.683	2
505	35/73	2
506	36/111	2
507	37/37	2
508	38/56	2
509	3808	2
510	3xsta	2
511	4/3π	2
512	4/83	2
513	5.84×10	2
514	5/69	2
515	62.15	2
516	63.7-97.0	2
517	65.21	2
518	7.4-11.5	2
519	7/93	2
520	75/234	2
521	8/93	2
522	80gy	2
523	9.4-12.4	2
524	9/43	2
525	=0.986	2
526	=1.91	2
527	a293	2
528	age=8.2	2
529	alb:05	2
530	ant-moa	2
531	ao-vti	2
532	asgaal	2
533	azetidin-2-one	2
534	bivm	2
535	bu-phoban	2
536	c-g-g	2
537	c.82g	2
538	c.y.wu	2
539	c/cm	2
540	c22:4	2
541	ce-c	2
542	cellulosomal	2
543	chilopoda	2
544	clinic-control	2
545	ct-control	2
546	cysts/mm	2
547	d+6	2
548	dalz	2
549	dermaptera	2
550	dichelyne	2
551	eco-s	2
552	ethyl-sulfanyl	2
553	ethylsulfanyl	2
554	eu0.01	2
555	eu0.03	2
556	f5/2→	2
557	fiss	2
558	flavanes	2
559	foam-sclerotherapy	2
560	gauthier	2
561	go-au/rusi	2
562	goodman-kruskal	2
563	gr-prp	2
564	gve/gva	2
565	h2-bibta	2
566	hexanic-leaf	2
567	hpv-cp8304	2
568	hr=1.17	2
569	i13/2→	2
570	i6	2
571	ie-3	2
572	insbs	2
573	isrctn79888843	2
574	kahneman	2
575	lactateinitial	2
576	lavmin	2
577	lialda	2
578	litten	2
579	lncrp	2
580	lsli	2
581	lys751gln	2
582	m/w	2
583	ma-c	2
584	mehta	2
585	met35red	2
586	mh5	2
587	mhlw-h	2
588	micen	2
589	mikrogen	2
590	mocl	2
591	myrtillin	2
592	n-acetylglucosaminidase	2
593	naal	2
594	nc-d	2
595	nci-h1993/nci-h1915	2
596	nct00389597	2
597	nct00416741	2
598	nct00528515	2
599	nct00537810	2
600	nct00667849	2
601	nct01286116	2
602	nme3	2
603	nonhdl-e	2
604	n⋯br	2
605	osteobiol®	2
606	oxa-gel	2
607	p/	2
608	p1.7-2,4	2
609	p1/2	2
610	palmolein	2
611	papacárie®	2
612	patgl=docgl	2
613	pb4	2
614	pglom	2
615	pns_1	2
616	portionsize	2
617	postbrochure	2
618	psg/r	2
619	pss-h	2
620	ptb-bo	2
621	quartermaster	2
622	quinazolin-4-ylthio	2
623	redness/greenness	2
624	rg-i	2
625	rhinocort	2
626	rho=0.27	2
627	rifater	2
628	rr=1.62	2
629	rr=1.8	2
630	rr=1.90	2
631	rr=2.31	2
632	sch727965	2
633	scolytinae	2
634	sedentary-placebo	2
635	self-moulded	2
636	sf-6d/hui3	2
637	shigyaku-to	2
638	st:04	2
639	sulfinylbis	2
640	taeum	2
641	tosyl	2
642	trfm	2
643	ud-fp-	2
644	uprima	2
645	valois	2
646	ventriguard	2
647	verum-	2
648	yb/tm	2
649	yca₄o	2
650	yce	2
651	z-2-	2
652	zyvox	2
653	±0.92	2
654	̇	2
655	δigf-1sds	2
656	∆lvedv	2
657	∆ppl	2
658	≤median	2
659	6/4	1
660	+0.0190	1
661	+0.0191	1
662	+0.6°	1
663	+1.20	1
664	+1.4°	1
665	+2.2°	1
666	+2.66	1
667	+4.1°	1
668	+h2o2	1
669	,14,16-triene	1
670	-0.06-0.14	1
671	-0.4mm	1
672	-0.643-8.443	1
673	-0.84+/-6.79	1
674	-0.94±0.30s	1
675	-0.98±0.23s	1
676	-0.98±0.26s	1
677	-1.00±0.24s	1
678	-1.32+0.54	1
679	-1.59u	1
680	-1.74±0.31s	1
681	-1.8-	1
682	-1.86/-1.01	1
683	-1.93±0.29s	1
684	-1.94±0.30s	1
685	-1.97±0.26s	1
686	-10.0+/-8.2	1
687	-10.50	1
688	-11.29±3.74	1
689	-121.93	1
690	-14.49	1
691	-15.63	1
692	-16.15	1
693	-17.7+/-2.2	1
694	-18.37±14.90	1
695	-2.98-	1
696	-23.84	1
697	-24.51-	1
698	-26.5mm	1
699	-2·69	1
700	-3.4-	1
701	-3.7-100	1
702	-31.12	1
703	-3178-	1
704	-34.75	1
705	-385.4	1
706	-4.14-0.05	1
707	-50977	1
708	-5·83	1
709	-6.52+/-11.43	1
710	-601	1
711	-605	1
712	-8.95±8.73	1
713	-8mm	1
714	-93/-4	1
715	-au/rusi	1
716	-cycloserine	1
717	-fe₃o₄	1
718	-pnkp	1
719	-\|ν	1
720	-€244	1
721	-€65	1
722	.030-.095	1
723	.18-.68	1
724	.27-.55	1
725	.31-.69	1
726	.97-1.12	1
727	//clinicaltrails.gov	1
728	//clinicaltrials.gov/ct2/show/nct00128570	1
729	//clinicaltrials.gov/ct2/show/nct00159874	1
730	//clinicaltrials.gov/ct2/show/nct00214383	1
731	//clinicaltrials.gov/ct2/show/nct00220974	1
732	//clinicaltrials.gov/ct2/show/nct00282009	1
733	//clinicaltrials.gov/ct2/show/nct00377208	1
734	//clinicaltrials.gov/ct2/show/nct00694018	1
735	//clinicaltrials.gov/ct2/show/nct00710658	1
736	//clinicaltrials.gov/ct2/show/nct00729040	1
737	//clinicaltrials.gov/ct2/show/nct00751985	1
738	//clinicaltrials.gov/ct2/show/nct00792207	1
739	//clinicaltrials.gov/ct2/show/nct00794222	1
740	//clinicaltrials.gov/ct2/show/nct00797628	1
741	//clinicaltrials.gov/ct2/show/nct00912795	1
742	//clinicaltrials.gov/ct2/show/nct01114919	1
743	//clinicaltrials.gov/ct2/show/nct01124110	1
744	//clinicaltrials.gov/ct2/show/nct01139255	1
745	//clinicaltrials.gov/ct2/show/nct01183520	1
746	//clinicaltrials.gov/ct2/show/nct01293253	1
747	//clinicaltrials.gov/ct2/show/nct01295203	1
748	//clinicaltrials.gov/ct2/show/nct01331564	1
749	//clinicaltrials.gov/ct2/show/nct01415492	1
750	//clinicaltrials.gov/ct2/show/nct01430286	1
751	//clinicaltrials.gov/ct2/show/nct01465217	1
752	//clinicaltrials.gov/ct2/show/nct01744535	1
753	//clinicaltrials.gov/ct2/show/nct01950091	1
754	//clinicaltrials.gov/ct2/show/nct02080585	1
755	//clinicaltrials.gov/show/nct00282009	1
756	//clinicaltrials.gov/show/nct00783315	1
757	//clinicaltrials.gov/show/nct00816725	1
758	//clinicaltrials.gov/show/nct00873899	1
759	//clinicaltrials.gov/show/nct00885677	1
760	//clinicaltrials.gov/show/nct00939081	1
761	//clinicaltrials.gov/show/nct00971009	1
762	//clinicaltrials.gov/show/nct00987285	1
763	//clinicaltrials.gov/show/nct01013844	1
764	//clinicaltrials.gov/show/nct01223170	1
765	//clinicaltrials.gov/show/nct01340079	1
766	//clinicaltrials.gov/show/nct01683617	1
767	//clinicaltrials.gov/show/nct01759368	1
768	//controlled-trials.com/isrctn25619675	1
769	//go.worldbank.org/d7sn0b8yu0	1
770	//iscrtn64669297	1
771	//isrctn80067039	1
772	//nct01452191	1
773	//nct01702142	1
774	//tkm.kiom.re.kr/ontology/traditionalkoreanmedicine.rdf-xml.owl	1
775	//www.anzctr.org.au/actrn12608000411347.aspx	1
776	//www.anzctr.org.au/actrn12609000819224.aspx	1
777	//www.anzctr.org.au/actrn12610000135011.aspx	1
778	//www.bcshguidelines.com/bcsh_process/evidence_levels_and_grades_of_recommendation/43_grade.html	1
779	//www.clinicaltrials.gov/ct2/show/nct00158639	1
780	//www.clinicaltrials.gov/ct2/show/nct00895700	1
781	//www.clinicaltrials.gov/ct2/show/nct00962494	1
782	//www.clinicaltrials.gov/ct2/show/nct01084018	1
783	//www.clinicaltrials.gov/ct2/show/nct01296321	1
784	//www.clinicaltrials.gov/ct2/show/nct01715649	1
785	//www.clinicaltrials.gov/ct2/show/nct01913496	1
786	//www.clinicaltrials.gov/ct2/show/nct02114788	1
787	//www.controlled-trials.com/isrctn/pf/55651027	1
788	//www.controlled-trials.com/isrctn07752711	1
789	//www.controlled-trials.com/isrctn16823487	1
790	//www.controlled-trials.com/isrctn19739792	1
791	//www.controlled-trials.com/isrctn24529487	1
792	//www.controlled-trials.com/isrctn24735383	1
793	//www.controlled-trials.com/isrctn24874457	1
794	//www.controlled-trials.com/isrctn31070347	1
795	//www.controlled-trials.com/isrctn31586428/	1
796	//www.controlled-trials.com/isrctn39104853	1
797	//www.controlled-trials.com/isrctn41034162	1
798	//www.controlled-trials.com/isrctn42687923/	1
799	//www.controlled-trials.com/isrctn45178534	1
800	//www.controlled-trials.com/isrctn48134476	1
801	//www.controlled-trials.com/isrctn48473735	1
802	//www.controlled-trials.com/isrctn50512934/	1
803	//www.controlled-trials.com/isrctn55651027	1
804	//www.controlled-trials.com/isrctn57754429	1
805	//www.controlled-trials.com/isrctn61819220	1
806	//www.controlled-trials.com/isrctn69603913	1
807	//www.controlled-trials.com/isrctn75058295	1
808	//www.controlled-trials.com/isrctn76298775	1
809	//www.controlled-trials.com/isrctn76460837	1
810	//www.controlled-trials.com/isrctn77864351	1
811	//www.controlled-trials.com/isrctn79864465	1
812	//www.controlled-trials.com/isrctn82153174	1
813	//www.controlled-trials.com/isrctn90110503/isrctn90110503	1
814	//www.controlled-trials.com/isrctn91623132	1
815	//www.controlled-trials.com/isrctn91879928	1
816	//www.controlled-trials.com/isrctn92107365/	1
817	//www.controlled-trials.com/isrctn93702927	1
818	//www.controlled-trials.com/isrctn93903959/	1
819	//www.controlled-trials.com/isrctn96595458	1
820	//www.controlled-trials.com/isrctn98176068	1
821	//www.controlled-trials.com/isrctn98560867	1
822	//www.ensaiosclinicos.gov.br/rg/rbr-7yhr4w/	1
823	//www.gsk-clinicalstudyregister.com	1
824	//www.gsk-clinicalstudywww.gsk-clinicalstudyregister.com	1
825	//www.isrctn.com/isrctn56326375	1
826	//www.register.clinicaltrials.gov/	1
827	//www.strokecenter.org/	1
828	//www.umin.ac.jp/ctr/listj/	1
829	//www.umin.ac.jp/english/	1
830	/df	1
831	/fe3o4	1
832	/pa-ea	1
833	/pom	1
834	/π	1
835	0.00-0.92	1
836	0.002-0.397	1
837	0.01-0.43	1
838	0.01-0.86	1
839	0.02-16.34microgg	1
840	0.03-1.87	1
841	0.05-0.95	1
842	0.06-1.30	1
843	0.080-0.859	1
844	0.0899	1
845	0.1,0.2	1
846	0.10-1.00	1
847	0.11-0.21	1
848	0.12-3.72	1
849	0.13-0.60	1
850	0.15-0.71	1
851	0.16-3.4	1
852	0.17-0.79	1
853	0.18-1.2	1
854	0.18–0.86	1
855	0.2-9.2	1
856	0.22-2.48	1
857	0.22–0.91	1
858	0.24-0.31	1
859	0.253v	1
860	0.26-0.40	1
861	0.28-1.41	1
862	0.29-1.0	1
863	0.2w/cm	1
864	0.30-5.59	1
865	0.33-0.55	1
866	0.33-132.8	1
867	0.331-0.696	1
868	0.34-1.74	1
869	0.348v	1
870	0.35-1.45	1
871	0.36-0.86	1
872	0.37-1.81	1
873	0.38-0.99	1
874	0.39-84.1	1
875	0.396*age	1
876	0.3±0.02×10	1
877	0.41-1.88	1
878	0.42-2.69	1
879	0.43-1.47	1
880	0.43-2.00	1
881	0.44-0.70	1
882	0.451-0.620	1
883	0.46-0.63	1
884	0.46-1.25	1
885	0.46-1.262	1
886	0.46-1.70	1
887	0.46-2.43	1
888	0.468ch50	1
889	0.47-1.37	1
890	0.48-1.85	1
891	0.48–1.14	1
892	0.49-2.05	1
893	0.49-4.27	1
894	0.4p	1
895	0.50-2.58μghml	1
896	0.50-2.83	1
897	0.54-1.32	1
898	0.54-1.76	1
899	0.56-4.46	1
900	0.60-1.35	1
901	0.60-1.40	1
902	0.61-1.96	1
903	0.610-0.970	1
904	0.614-0.979	1
905	0.62-1.58	1
906	0.625-0.970	1
907	0.63-1.87	1
908	0.639-0.904	1
909	0.64-2.07	1
910	0.64-6.63	1
911	0.66-1.23	1
912	0.66-1.40	1
913	0.66-2.02	1
914	0.66-8.10	1
915	0.668-0.947	1
916	0.67-1.30	1
917	0.67-7.06	1
918	0.68-1.96	1
919	0.685min	1
920	0.69-1.32	1
921	0.6±0.05×10	1
922	0.7-1.91	1
923	0.71-3.25	1
924	0.71-3.94	1
925	0.7214	1
926	0.75-1.98	1
927	0.777-1.532	1
928	0.781×	1
929	0.80-1	1
930	0.80-3.20	1
931	0.82-	1
932	0.8232	1
933	0.824-0.904	1
934	0.83-11.7	1
935	0.84-1.59	1
936	0.86-1.003	1
937	0.87-1.16	1
938	0.87-1.57	1
939	0.88-1.85	1
940	0.88-2.10	1
941	0.89-11.01	1
942	0.9-18.0	1
943	0.905×10	1
944	0.91-2.61	1
945	0.92-1.2	1
946	0.93-2.33	1
947	0.94-4.08	1
948	0.95-13.68	1
949	0.96-5.61	1
950	0.960-0.976	1
951	0.98-2.24	1
952	0.98-3.39	1
953	0.984-0.992	1
954	0.988-0.995	1
955	0.99-2.63	1
956	0/109	1
957	0455	1
958	05.134	1
959	08:00-15:59	1
960	0:23-0:26	1
961	0:58-1:19	1
962	0ima	1
963	0·13-0·54	1
964	0·5-2·9	1
965	0·57-1·24	1
966	0·8-2·9	1
967	1,2-butadiene	1
968	1,3,4-thiadiazolium-5-methylthio-	1
969	1,3-dimethylol-5,5-dimethylhydantoin	1
970	1-metylo-2-	1
971	1.0-34.9	1
972	1.0-83.3	1
973	1.01-2.36	1
974	1.01-2.39	1
975	1.01-3.059	1
976	1.01-3.81	1
977	1.011-1.063	1
978	1.02-103.95	1
979	1.02-13.81	1
980	1.02-2.69	1
981	1.022-1.082	1
982	1.024x	1
983	1.03-2.08	1
984	1.03-2.5	1
985	1.03-5.98	1
986	1.03-6.41	1
987	1.04-1.76	1
988	1.048-4.761	1
989	1.05-2.63	1
990	1.05-3.46	1
991	1.05-3.70	1
992	1.05-3.76	1
993	1.06-1.29	1
994	1.06-1.36	1
995	1.06-37.19	1
996	1.06-4.50	1
997	1.06-7.36	1
998	1.07-13.22	1
999	1.07-2.76	1
1000	1.07-5.57	1
1001	1.08-1.97	1
1002	1.08-3.98	1
1003	1.09-1.29	1
1004	1.09-2.37	1
1005	1.09-3.56	1
1006	1.09-3.79	1
1007	1.10-1.94	1
1008	1.10-11.96	1
1009	1.11-1.35	1
1010	1.11-4.18	1
1011	1.11-6.62	1
1012	1.12-1.18/1.03-1.09	1
1013	1.12-1.31	1
1014	1.12-1.32	1
1015	1.12-3.24	1
1016	1.13-1.92	1
1017	1.13-3.8	1
1018	1.14-1.150	1
1019	1.15-1.36	1
1020	1.15-3.16	1
1021	1.15/1.06	1
1022	1.16-7.73	1
1023	1.17-1.64	1
1024	1.17-132.3	1
1025	1.18-2.33	1
1026	1.18-5.94	1
1027	1.18-6.97	1
1028	1.19-8.26	1
1029	1.2-10.2	1
1030	1.20,3.71	1
1031	1.21-2.74	1
1032	1.21-2.80	1
1033	1.21-5.8	1
1034	1.22-2.19	1
1035	1.25-1.59	1
1036	1.26-2.09	1
1037	1.26-200.00	1
1038	1.26-24.72	1
1039	1.26-6.52	1
1040	1.27-1.63	1
1041	1.27-2.88	1
1042	1.27-3.10	1
1043	1.27-52.50	1
1044	1.28-1.56	1
1045	1.28-4.89	1
1046	1.28-6.19	1
1047	1.29-1.69	1
1048	1.29-8.12	1
1049	1.3-7.80	1
1050	1.3096-39.6802	1
1051	1.31-1.53	1
1052	1.31-2.93	1
1053	1.31-2.96	1
1054	1.32-1.55	1
1055	1.36-2.02	1
1056	1.36-6.96	1
1057	1.37-1.62	1
1058	1.38-14.5	1
1059	1.383-3.109	1
1060	1.39-1.64	1
1061	1.40-1.66	1
1062	1.40-5.58	1
1063	1.41-1.85	1
1064	1.41±1.55	1
1065	1.43-12.82	1
1066	1.43-2.79	1
1067	1.43-3.90	1
1068	1.49-8.03	1
1069	1.50-12.02	1
1070	1.51-3.97	1
1071	1.52-1.90	1
1072	1.52-3.88	1
1073	1.52-5.74	1
1074	1.53-9.61	1
1075	1.58-1.91	1
1076	1.59-37.17	1
1077	1.6-10.9	1
1078	1.6-8.5	1
1079	1.60-11.37	1
1080	1.61-1.85	1
1081	1.63-19.8	1
1082	1.63-6.43	1
1083	1.68-3.44	1
1084	1.69-6.75	1
1085	1.69-9.90	1
1086	1.708-6.373	1
1087	1.711	1
1088	1.72-17.42	1
1089	1.729-4.997	1
1090	1.73-10.25	1
1091	1.73-2.80	1
1092	1.76-24.59	1
1093	1.76-4.55	1
1094	1.79-6.73	1
1095	1.8-8.7	1
1096	1.88-6.79	1
1097	1.89-4.04	1
1098	1.9-2-1	1
1099	1.90-10.24	1
1100	1.92-2.37	1
1101	1.95-2.32	1
1102	1.95-7.99	1
1103	1/226	1
1104	10.36-19.03	1
1105	10.85-15.30	1
1106	10.87-12.7	1
1107	10/495	1
1108	100/290	1
1109	1009/1276	1
1110	10215	1
1111	104-432	1
1112	105.7-108.6	1
1113	1059-1068	1
1114	106369	1
1115	107/415	1
1116	107998	1
1117	107·5	1
1118	109-117	1
1119	11,12-dhet	1
1120	11,99	1
1121	11.2-44.5	1
1122	11.26±1.96	1
1123	11.6-24.6	1
1124	11.7-18.0	1
1125	11.9-45.9	1
1126	11.mpcwp	1
1127	112.5j/cm	1
1128	113.69	1
1129	114.1-225.4	1
1130	115/159	1
1131	115/177	1
1132	115·0	1
1133	116.14ngg	1
1134	118-517	1
1135	118·2	1
1136	119/732	1
1137	12,30-di-aza-hepta-cyclo	1
1138	12,420	1
1139	12.7-60.2	1
1140	12/107	1
1141	12/165	1
1142	12/273	1
1143	123-37,553	1
1144	126.64gycm	1
1145	126/196	1
1146	128.34	1
1147	13*/-6	1
1148	13.8-21.2	1
1149	13/2591	1
1150	13102-13113	1
1151	132.63	1
1152	132/989	1
1153	134/151	1
1154	135-418	1
1155	135.7±10.9	1
1156	136-143	1
1157	1366.4	1
1158	14/172	1
1159	140/196	1
1160	143/419	1
1161	146/251	1
1162	15.53-33.27	1
1163	15/93	1
1164	151.67	1
1165	151.68	1
1166	157/810	1
1167	16.2-21.8	1
1168	16.2-62.7	1
1169	16/129	1
1170	166-171	1
1171	167/279	1
1172	177/196	1
1173	178-183	1
1174	18.0-45.0	1
1175	180.02gycm	1
1176	183,452	1
1177	185.24-274.70	1
1178	185/246	1
1179	18hcrp	1
1180	19.8-27.0	1
1181	19/167	1
1182	194:66	1
1183	198-205	1
1184	1cm3	1
1185	1·048	1
1186	1·06-1·95	1
1187	1·07-1·83	1
1188	1·090	1
1189	1·099	1
1190	1·139	1
1191	1·8-2·1	1
1192	2',3'-c	1
1193	2'-o-acetyldihydropenstemide	1
1194	2-megapixel	1
1195	2-methoxy-n-	1
1196	2-o-methyl-l-chiro-inositol	1
1197	2.04-5.07	1
1198	2.04-8.77	1
1199	2.07-98.28	1
1200	2.07±0.98×10	1
1201	2.1-5.7	1
1202	2.10-2.93	1
1203	2.11-5.32	1
1204	2.1·10	1
1205	2.25/month	1
1206	2.2±2.7	1
1207	2.33-2.38	1
1208	2.37-5.98	1
1209	2.398	1
1210	2.39×10	1
1211	2.43-42.35	1
1212	2.44-7.41	1
1213	2.4months	1
1214	2.4±0.09	1
1215	2.5-296.1	1
1216	2.5-30.5	1
1217	2.514-20.575	1
1218	2.58±0.72×10	1
1219	2.66-3.28	1
1220	2.7-28.5	1
1221	2.73-3.00	1
1222	2.8-35	1
1223	2.82-6.52	1
1224	2.93-6.35	1
1225	2.94-3.77	1
1226	2.ae+prime	1
1227	20.4-27.0	1
1228	20/76/76/15	1
1229	2008-000583-16	1
1230	2008_06	1
1231	2011-003243-21	1
1232	2012-003343-29	1
1233	2012-005511-11	1
1234	203.54ngg	1
1235	2066-2073	1
1236	20°c/20°c	1
1237	20·04	1
1238	20·06	1
1239	21,779	1
1240	21.2-56.4	1
1241	21.9±1.7kg/m	1
1242	211.66	1
1243	216/605	1
1244	22.1-28.8	1
1245	22.8-29.2	1
1246	23/129	1
1247	23/187	1
1248	23/371	1
1249	235-240	1
1250	23·00	1
1251	24,74	1
1252	24.6pmol/l	1
1253	24/454	1
1254	2460-4665	1
1255	25-169	1
1256	252-396	1
1257	26.1-102.1	1
1258	26.9-48.1	1
1259	26/108	1
1260	26/174	1
1261	2625ml	1
1262	268.3	1
1263	27/158	1
1264	273.9	1
1265	28,398	1
1266	28.0-34.4	1
1267	28.4±0.5×10	1
1268	282/2615	1
1269	29-160	1
1270	29/586	1
1271	2951-6609	1
1272	2:02-2:14	1
1273	2p23-24	1
1274	2π	1
1275	3'-c-ethynylcytidine	1
1276	3'-o-methyltaxifolin	1
1277	3,300,708	1
1278	3,387	1
1279	3.1-11.2	1
1280	3.1-7.6	1
1281	3.11±1.84×10	1
1282	3.15-5.61	1
1283	3.3-64.8	1
1284	3.4-16.5	1
1285	3.4-19.2	1
1286	3.42/month	1
1287	3.5/3.7	1
1288	3.552	1
1289	3.88-9.29	1
1290	3/155	1
1291	3/163	1
1292	3/234	1
1293	30.51-62.30	1
1294	301-621	1
1295	308.35	1
1296	30·23	1
1297	312.8	1
1298	326.15	1
1299	33.2±1.1×10	1
1300	333-46	1
1301	33μg/kg/day	1
1302	34,286	1
1303	34.3-38.1	1
1304	34/89	1
1305	3487±978.5	1
1306	349.9	1
1307	35.6-57.8	1
1308	352/1091	1
1309	3569.2	1
1310	36.35°c	1
1311	36.3±5.4kg/m	1
1312	36/190	1
1313	36/547	1
1314	370/429	1
1315	372/mm	1
1316	378.0	1
1317	37±15hour	1
1318	38.5-60.9	1
1319	391-3452	1
1320	393.20	1
1321	3:43-4:16	1
1322	3pter	1
1323	3·28-9·29	1
1324	4,24	1
1325	4,4-dimethyl-2-	1
1326	4-acetyl-3-	1
1327	4-amino-2,2-bis	1
1328	4-halogeno-n-	1
1329	4-phenyl-1,2,4-triazole-3,5-dione	1
1330	4.1-16	1
1331	4.1-17.1	1
1332	4.4/4.8	1
1333	4.5/4.6	1
1334	4.6±4.4pmoll	1
1335	4.779	1
1336	4.8-20.8	1
1337	4.84-843.2	1
1338	4.95-10.84	1
1339	4009	1
1340	41.594l	1
1341	41/10	1
1342	41/190	1
1343	41patients	1
1344	42,591	1
1345	42.22-	1
1346	42/540	1
1347	420/1,106	1
1348	43.0-54.8	1
1349	432/497	1
1350	44,72	1
1351	44/68	1
1352	446.3	1
1353	46.6±2.7×10	1
1354	46/101	1
1355	46/190	1
1356	46/216	1
1357	461-466	1
1358	466.6	1
1359	469/mm	1
1360	48.2kpa	1
1361	481/574	1
1362	482.1	1
1363	493-978	1
1364	495-502	1
1365	4:19-4:38	1
1366	5,6,4'-trihydroxy-7,8-dimethoxyflavone	1
1367	5.13-9.15	1
1368	5.7-55.1	1
1369	5.7-8.6	1
1370	5.89-13.06	1
1371	5/114	1
1372	5/292	1
1373	50-89mg/m	1
1374	50.0-98.7	1
1375	51.4-69.6	1
1376	514c	1
1377	52.5-71.5	1
1378	522/f	1
1379	52937	1
1380	52±22	1
1381	53.66gycm	1
1382	54/495	1
1383	55.57	1
1384	55/169	1
1385	55/186	1
1386	5534201182098351	1
1387	56.3-67.9	1
1388	561.79	1
1389	57/118	1
1390	58.1±5.2×10	1
1391	59.5-76.5	1
1392	5a-5o	1
1393	5s2,5f4	1
1394	5u/ml	1
1395	6.3-14.4	1
1396	6.5-21.1	1
1397	6.6±3.5×10	1
1398	6.75m/s	1
1399	6.97-11.21	1
1400	6.97-9.40	1
1401	63-92	1
1402	633.6	1
1403	637.6	1
1404	64.2±6.5mlkg	1
1405	642g	1
1406	65.6-66.1	1
1407	65/148	1
1408	67,600	1
1409	68.4-72.9	1
1410	6878	1
1411	7-lsign	1
1412	7-phenyl-7-	1
1413	7.24×10	1
1414	7.4-13.7	1
1415	7.4-15.7	1
1416	7.6-26.5	1
1417	7/56	1
1418	70/84	1
1419	713-718	1
1420	727-33	1
1421	7293	1
1422	73187232	1
1423	732,009	1
1424	754-762	1
1425	76737502	1
1426	77/84	1
1427	7778	1
1428	78/95	1
1429	79.0±1.7×10	1
1430	8,8'dimethyl-3,4,3',4'-dimethylenedioxy-7-oxo-2,7'cyclolignan	1
1431	8.09/6.07	1
1432	8.5-9.7	1
1433	8.5±6.6×10	1
1434	8.6-10.7	1
1435	8.67-18.14	1
1436	8.8-28.3	1
1437	8.83-15.28	1
1438	8/351	1
1439	80/206	1
1440	81-207	1
1441	812-824	1
1442	82.914	1
1443	82/547	1
1444	830-844	1
1445	84.9-99.5	1
1446	86.6-102.3	1
1447	87.5±3.8×10	1
1448	87.7-165.8	1
1449	87.9-94.4	1
1450	87/284	1
1451	88.2-94.6	1
1452	88.27	1
1453	9.3-22.0	1
1454	9.5·10	1
1455	9.lvedp	1
1456	9/172	1
1457	92/171	1
1458	93.1-98.8	1
1459	93.4kpa	1
1460	93/255	1
1461	95/5/0.05	1
1462	973-981	1
1463	9gammat4/	1
1464	:18q21.1	1
1465	:18q23	1
1466	:21q22.1	1
1467	:3q12	1
1468	:beta-glucuronidase-reporter	1
1469	:egfp	1
1470	a-diet	1
1471	a-hypertensive	1
1472	a-receiving	1
1473	a.nelson	1
1474	a/ussr/77	1
1475	a49g	1
1476	a=8.4749	1
1477	a=fluorouracil-epirubicin-cyclophosphamide	1
1478	actrn12609000257268	1
1479	actrn12610000604000	1
1480	actrn12611001032943	1
1481	actrn12612001281886	1
1482	actrn12614000995673	1
1483	adolphs	1
1484	adp-fe	1
1485	agassiz	1
1486	aiai	1
1487	akinetic-dyskinetic	1
1488	albion:2005	1
1489	alcohol/drug-revised	1
1490	aldao	1
1491	algna/fe₃o₄	1
1492	altmann	1
1493	alwar	1
1494	amd=-11.9	1
1495	amd=-8.1	1
1496	amerman	1
1497	amidon	1
1498	aml2	1
1499	anaconda®	1
1500	androsteredione	1
1501	anti-diphteria	1
1502	aq*	1
1503	arg339gln	1
1504	arnarson	1
1505	asistencia	1
1506	aunano	1
1507	aux-cc-857	1
1508	ay349182.1	1
1509	barû	1
1510	baumstark	1
1511	behbehani	1
1512	beier	1
1513	bendall-lyon	1
1514	beta=1.84	1
1515	biological/physical	1
1516	birrd	1
1517	bluephaseg2	1
1518	blyth	1
1519	bmi=27-45kg/m	1
1520	bonnier	1
1521	bospa	1
1522	boyes	1
1523	brainerd	1
1524	bronchitis/pneumonia/bronchopneumonia	1
1525	buckup	1
1526	bupo3h2	1
1527	butorphanol/saline	1
1528	c.139delg	1
1529	c.1670-191c	1
1530	c000000146	1
1531	c4h3o-cho	1
1532	ca4lao	1
1533	cacbtp=3.46	1
1534	cahsp25.99n	1
1535	cam:171:09	1
1536	camaguey:171:2009	1
1537	canestri	1
1538	cd004602	1
1539	cd31/cd34	1
1540	cdsmp-plus-exercise	1
1541	cendres	1
1542	chamisso	1
1543	chictr-trc-11001614	1
1544	chictr-trc-12002174	1
1545	chictr-trc-12002718	1
1546	chictr-trc-13003594	1
1547	chictr-trc-13003661	1
1548	chictr-trc-14004720	1
1549	chlorhexidine-metronidazole	1
1550	cholesterol-0-acyltransferase	1
1551	claparede	1
1552	classi	1
1553	clearfil-s3	1
1554	cmax=18.50	1
1555	cmax=7.06	1
1556	cmax=77.7	1
1557	cmax=81.2	1
1558	cns-1	1
1559	cold-fx	1
1560	condylion-pogonion	1
1561	control-fat	1
1562	corbridge	1
1563	cordis/johnson	1
1564	cormac	1
1565	cr-before	1
1566	crasilneck	1
1567	crp=21.7	1
1568	cuhk_cct00347	1
1569	d-201-15004	1
1570	d9-phosphatidylcholine	1
1571	d=-0.18	1
1572	deffenbacher	1
1573	dehydration-placebo	1
1574	deltag0	1
1575	deltandhb	1
1576	desenvolvimento	1
1577	diacylglyceroltransferase-1	1
1578	diaroot	1
1579	dihydro-artemisinin-piperaquine	1
1580	diolylphosphatidylethanolamine	1
1581	ditre	1
1582	dnad-devd-t	1
1583	docetaxel+oxaliplatin	1
1584	docetaxel+oxaliplatin+cetuximab	1
1585	dosage/	1
1586	downtraining	1
1587	drcf-dwarf	1
1588	drks00000443	1
1589	drks00003589	1
1590	drks00005223	1
1591	duofluorid	1
1592	durafluor	1
1593	e-flow	1
1594	e43893	1
1595	early-control	1
1596	edronax-pharmacia	1
1597	een+glutamine	1
1598	egner	1
1599	emm15	1
1600	epivir®	1
1601	erkens	1
1602	es=-0.45	1
1603	es=0.39	1
1604	es=0.61	1
1605	etch+prime	1
1606	etch-and-rinse/rubber-dam	1
1607	euphyodesmusphilippina	1
1608	ev=23	1
1609	exposure_long	1
1610	exposure_short	1
1611	f29	1
1612	figner	1
1613	fk719875–fk759813	1
1614	forward-left	1
1615	g-pre	1
1616	g.44369_50449dup	1
1617	g04	1
1618	g1-excavator	1
1619	g10-p	1
1620	g8-p	1
1621	galacto-oligosaccharide/fructo-oligosaccharide	1
1622	ganzfeld-electroretinography	1
1623	garaigordobil	1
1624	gaston	1
1625	gaudiano	1
1626	gbp/placebo	1
1627	gdvo	1
1628	ge12	1
1629	ge8as4	1
1630	ge8as6	1
1631	ginsenoside-rb1	1
1632	gonion-menton	1
1633	goodacre	1
1634	gr-dlc	1
1635	ground-glass-opacity	1
1636	gstp1*b	1
1637	h-pyrazol-1-yl	1
1638	h45	1
1639	h65-h75	1
1640	ha8	1
1641	hager	1
1642	hales	1
1643	hba2-yialousa	1
1644	hemodynamic-obesity	1
1645	hepper	1
1646	hepta-cyclo	1
1647	herpv+qs-21	1
1648	hexahydro-2a,4a,6a-triaza-6b-phosphacyclopenta	1
1649	ht=41.5	1
1650	hyper-tg	1
1651	hυ	1
1652	i-control	1
1653	i-ing	1
1654	i9/2	1
1655	iib-positive	1
1656	ilc1s	1
1657	in-labeled-spio	1
1658	industry=27.9	1
1659	inferior/+rv	1
1660	intensive/indoor	1
1661	intermontana	1
1662	irct2014050317534n1	1
1663	isaacowitz	1
1664	isrctn03000938	1
1665	isrctn05346737	1
1666	isrctn17436693	1
1667	isrctn21710246	1
1668	isrctn27312291	1
1669	isrctn32464251	1
1670	isrctn46295339	1
1671	isrctn61861069	1
1672	isrctn67338640	1
1673	janssen/j	1
1674	jingbie	1
1675	jjg	1
1676	jmc	1
1677	k.d.hill	1
1678	kamiuntanto	1
1679	kapson	1
1680	kashy	1
1681	kellegren	1
1682	ki-vlok-63	1
1683	kibel	1
1684	km1/3-gm3/17	1
1685	la	1
1686	l-d-	1
1687	l126c	1
1688	lallave	1
1689	laminaria-d	1
1690	large-for-ga	1
1691	lcos3060	1
1692	lemée	1
1693	libbs	1
1694	liquid/powder	1
1695	lo-asca	1
1696	lta/vn	1
1697	m184c	1
1698	m=2:1	1
1699	m=methylprednisolone	1
1700	male-87	1
1701	malkjovic	1
1702	massoud	1
1703	mcconkie	1
1704	mcpyv-positive	1
1705	md-0.03	1
1706	medtronic-electrodes	1
1707	mi/mii	1
1708	millaurine	1
1709	milosevic	1
1710	minicog	1
1711	mmancano	1
1712	moderate-f	1
1713	moderate-resistance-moderate-endurance	1
1714	monson	1
1715	mychen	1
1716	myricetin-3-o-arabinopyranoside	1
1717	n-placebo	1
1718	n-stearoylethanolamine	1
1719	na-hco3	1
1720	naemi	1
1721	nct00049829	1
1722	nct00090103	1
1723	nct00151528	1
1724	nct00170352	1
1725	nct00197743	1
1726	nct00259012	1
1727	nct00272701	1
1728	nct00273663	1
1729	nct00319215	1
1730	nct00326001	1
1731	nct00326287	1
1732	nct00363896	1
1733	nct00374166	1
1734	nct00400153	1
1735	nct00467142	1
1736	nct00469872	1
1737	nct00473499	1
1738	nct00497549	1
1739	nct00534235	1
1740	nct00540462	1
1741	nct00542308	1
1742	nct00573560	1
1743	nct00607243	1
1744	nct00643448	1
1745	nct00680056	1
1746	nct00747253	1
1747	nct00768755	1
1748	nct00792532	1
1749	nct00808496	1
1750	nct00833248	1
1751	nct00837811	1
1752	nct00875173	1
1753	nct00881894	1
1754	nct00902174	1
1755	nct00923403	1
1756	nct01044316	1
1757	nct01050517	1
1758	nct01059760	1
1759	nct01075633	1
1760	nct01078012	1
1761	nct01078818	1
1762	nct01097031	1
1763	nct01103258	1
1764	nct01112241	1
1765	nct01169454	1
1766	nct01182038	1
1767	nct01209364	1
1768	nct01254383	1
1769	nct01264406	1
1770	nct01306175	1
1771	nct01329770	1
1772	nct01348048	1
1773	nct01389622	1
1774	nct01465685	1
1775	nct01478503	1
1776	nct01511341	1
1777	nct01593267	1
1778	nct01608048	1
1779	nct01609504	1
1780	nct01638962	1
1781	nct01641185	1
1782	nct01649973	1
1783	nct01650025	1
1784	nct01676987	1
1785	nct01697358	1
1786	nct01737281	1
1787	nct01737853	1
1788	nct01748058	1
1789	nct01761435	1
1790	nct01774669	1
1791	nct01781585	1
1792	nct01785316	1
1793	nct01802099	1
1794	nct01849172	1
1795	nct01929993	1
1796	nct01978392	1
1797	nct02021513	1
1798	nct02027194	1
1799	nct02028195	1
1800	nct02048553	1
1801	nct02124226	1
1802	nct02146053	1
1803	nct02151162	1
1804	nct02232945	1
1805	nct02236455	1
1806	neurolept-	1
1807	nevill	1
1808	ngt/low	1
1809	nhe1-5	1
1810	nhe6-9	1
1811	no-lsm-placebo	1
1812	nol-320	1
1813	nonadecanol	1
1814	none.192	1
1815	normal-pi	1
1816	normal/increased	1
1817	ntr1386	1
1818	ntr1806	1
1819	ntr567	1
1820	nuk	1
1821	null-mutation	1
1822	nygaard	1
1823	n→σ	1
1824	o.7	1
1825	obstetricans	1
1826	oc-0.95	1
1827	octyl-p-methoxycinnamate	1
1828	oh=3.7:1	1
1829	olineck	1
1830	olivers	1
1831	opp=	1
1832	or=0.04	1
1833	or=7.58	1
1834	or=8.91	1
1835	oregonin	1
1836	orlinsky	1
1837	orr=3.32	1
1838	osa/mets	1
1839	ovary/peritoneal	1
1840	p164	1
1841	p=p	1
1842	pactr201102000277177	1
1843	paroxetine-escitalopram	1
1844	pb10	1
1845	pck-technique	1
1846	pd142893	1
1847	perruchet	1
1848	pglu-leu-asn-phe-ser-pro-gly-trp	1
1849	phenyl-c61-butyric-acid-methylester	1
1850	phosphoaspartyl-pnkp	1
1851	pizzo	1
1852	placebo/gbp	1
1853	plasmacontrol	1
1854	plavix-sanofi	1
1855	plavix-sanofi-synthelabo	1
1856	poepp.	1
1857	polymethoxyethylacrylate	1
1858	polypeptide-o-beta-acetylglucosaminyltransferase	1
1859	polystyrenesulfonate	1
1860	poor-good	1
1861	post-t	1
1862	postcard/letter/pamphlets	1
1863	pre-fev	1
1864	prepropranolol	1
1865	protoaphin-fb	1
1866	pss/	1
1867	pγ	1
1868	qbblind	1
1869	qbopen	1
1870	quoy	1
1871	rad-i	1
1872	rnapc2	1
1873	roelfsema	1
1874	rotational-	1
1875	rpcec00000075	1
1876	rr=0.29	1
1877	rr=0.767	1
1878	rr=1.700	1
1879	rs1039084	1
1880	rs11694911	1
1881	rs4606	1
1882	rs9554316	1
1883	rs=0.17	1
1884	s+/p+	1
1885	s0167-5273	1
1886	s125n	1
1887	s25-s33	1
1888	sand-blasting	1
1889	sanjappa	1
1890	sappanin-type	1
1891	sarocladium	1
1892	satogun	1
1893	scch	1
1894	schoenmakers	1
1895	self-anger	1
1896	severity-adhd	1
1897	sevoflurane-lidocaine-tourniquet	1
1898	sftpa1	1
1899	sham+saline	1
1900	ship0804	1
1901	sistostenone	1
1902	sitagliptin-treatment	1
1903	smd=0.33	1
1904	smlat	1
1905	spapankvphsaanlplrf-nh2	1
1906	spirit-calling	1
1907	spotting/bleeding	1
1908	ss:03	1
1909	sse1/sse2	1
1910	starns	1
1911	steane	1
1912	subcontinuous	1
1913	szechtman	1
1914	t355c4326g-1293	1
1915	ta-nic	1
1916	tadip	1
1917	tag:05	1
1918	taguasco:2005	1
1919	text-comprehension	1
1920	tillman	1
1921	tn-tn-tn	1
1922	todaearly	1
1923	toegepast	1
1924	top2alpha	1
1925	triazole-3-thiol	1
1926	tsc22d3	1
1927	tvie/tvia	1
1928	u1111-1127-9390	1
1929	ubiquinone-oxidoreductase	1
1930	ultraminilaparotomy	1
1931	umin000005682	1
1932	umin000007833	1
1933	umin000009118	1
1934	variotin	1
1935	victor-e3	1
1936	vlok	1
1937	wall-motion-score-index	1
1938	wasmund	1
1939	wattakaka	1
1940	whitford	1
1941	windschitl	1
1942	wt×wt	1
1943	www.clinicaltrials.gov/ct2/show/nct01134705	1
1944	xce	1
1945	y=0.15e	1
1946	y=0.21e	1
1947	ych3nh3cl	1
1948	yellow-poplar	1
1949	yodt	1
1950	younger-placebo	1
1951	yttrium–aluminum–garnet	1
1952	z-gly-pro-phe-4	1
1953	zentall	1
1954	zhdanov	1
1955	zno/zn	1
1956	znp-s-pcbd	1
1957	~380	1
1958	α-agonists	1
1959	β1,3-galactosyltransferase‑4	1
1960	β=-2.4×10	1
1961	β=-2.82	1
1962	β=8.82	1
1963	δgwt	1
1964	δiief-ef	1
1965	σ0=881	1
1966	σ0=898	1
1967	σ0=921	1
1968	σ0=930	1
1969	σ0=973	1
1970	χ2=0.2	1
1971	χ2=4.2	1
1972	χ2=4.3	1
1973	€2,397	1
1974	€222.30	1
1975	€3450	1
1976	€517.52	1
1977	€860.76	1
1978	≥3.78	1
1979	≥67.0°	1
1980	⩾75years	1

Words in alphabetical order

1	6/4	1
2	+0.0190	1
3	+0.0191	1
4	+0.6°	1
5	+1.20	1
6	+1.4°	1
7	+2.2°	1
8	+2.66	1
9	+2.6°	2
10	+4.1°	1
11	+h2o2	1
12	,14,16-triene	1
13	-0.06-0.14	1
14	-0.307	2
15	-0.4mm	1
16	-0.512	5
17	-0.643-8.443	1
18	-0.84+/-6.79	1
19	-0.94±0.30s	1
20	-0.98±0.23s	1
21	-0.98±0.26s	1
22	-0·50	2
23	-1.00±0.24s	1
24	-1.32+0.54	1
25	-1.59u	1
26	-1.74±0.31s	1
27	-1.8-	1
28	-1.86/-1.01	1
29	-1.93±0.29s	1
30	-1.94±0.30s	1
31	-1.97±0.26s	1
32	-10.0+/-8.2	1
33	-10.50	1
34	-11.29±3.74	1
35	-121.93	1
36	-14.49	1
37	-15.63	1
38	-16.15	1
39	-17.7+/-2.2	1
40	-18.37±14.90	1
41	-2.583	2
42	-2.890	2
43	-2.98-	1
44	-23.84	1
45	-24.51-	1
46	-26.5mm	1
47	-2·69	1
48	-3.4-	1
49	-3.7-100	1
50	-31.12	1
51	-3178-	1
52	-34.75	1
53	-385.4	1
54	-4.14-0.05	1
55	-50977	1
56	-5·83	1
57	-6.52+/-11.43	1
58	-601	1
59	-605	1
60	-8.95±8.73	1
61	-8mm	1
62	-93/-4	1
63	-arginine	7
64	-aspartate	2
65	-au/rusi	1
66	-cycloserine	1
67	-factor	2
68	-fe₃o₄	1
69	-intention-to-treat	2
70	-log	5
71	-no	15
72	-pnkp	1
73	-\|ν	1
74	-€244	1
75	-€65	1
76	.030-.095	1
77	.18-.68	1
78	.27-.55	1
79	.31-.69	1
80	.97-1.12	1
81	//	15
82	//clinicaltrails.gov	1
83	//clinicaltrials.gov/ct2/show/nct00128570	1
84	//clinicaltrials.gov/ct2/show/nct00159874	1
85	//clinicaltrials.gov/ct2/show/nct00169312	2
86	//clinicaltrials.gov/ct2/show/nct00214383	1
87	//clinicaltrials.gov/ct2/show/nct00220974	1
88	//clinicaltrials.gov/ct2/show/nct00282009	1
89	//clinicaltrials.gov/ct2/show/nct00377208	1
90	//clinicaltrials.gov/ct2/show/nct00694018	1
91	//clinicaltrials.gov/ct2/show/nct00710658	1
92	//clinicaltrials.gov/ct2/show/nct00721786	2
93	//clinicaltrials.gov/ct2/show/nct00729040	1
94	//clinicaltrials.gov/ct2/show/nct00751985	1
95	//clinicaltrials.gov/ct2/show/nct00792207	1
96	//clinicaltrials.gov/ct2/show/nct00794222	1
97	//clinicaltrials.gov/ct2/show/nct00797628	1
98	//clinicaltrials.gov/ct2/show/nct00912795	1
99	//clinicaltrials.gov/ct2/show/nct00992264	2
100	//clinicaltrials.gov/ct2/show/nct01114919	1
101	//clinicaltrials.gov/ct2/show/nct01124110	1
102	//clinicaltrials.gov/ct2/show/nct01139255	1
103	//clinicaltrials.gov/ct2/show/nct01183520	1
104	//clinicaltrials.gov/ct2/show/nct01293253	1
105	//clinicaltrials.gov/ct2/show/nct01295203	1
106	//clinicaltrials.gov/ct2/show/nct01331564	1
107	//clinicaltrials.gov/ct2/show/nct01415492	1
108	//clinicaltrials.gov/ct2/show/nct01430286	1
109	//clinicaltrials.gov/ct2/show/nct01465217	1
110	//clinicaltrials.gov/ct2/show/nct01469689	2
111	//clinicaltrials.gov/ct2/show/nct01744535	1
112	//clinicaltrials.gov/ct2/show/nct01950091	1
113	//clinicaltrials.gov/ct2/show/nct02080585	1
114	//clinicaltrials.gov/show/nct00282009	1
115	//clinicaltrials.gov/show/nct00783315	1
116	//clinicaltrials.gov/show/nct00816725	1
117	//clinicaltrials.gov/show/nct00873899	1
118	//clinicaltrials.gov/show/nct00885677	1
119	//clinicaltrials.gov/show/nct00939081	1
120	//clinicaltrials.gov/show/nct00971009	1
121	//clinicaltrials.gov/show/nct00987285	1
122	//clinicaltrials.gov/show/nct01013844	1
123	//clinicaltrials.gov/show/nct01223170	1
124	//clinicaltrials.gov/show/nct01340079	1
125	//clinicaltrials.gov/show/nct01683617	1
126	//clinicaltrials.gov/show/nct01759368	1
127	//controlled-trials.com/isrctn25619675	1
128	//go.worldbank.org/d7sn0b8yu0	1
129	//iscrtn64669297	1
130	//isrctn80067039	1
131	//nct01452191	1
132	//nct01702142	1
133	//tkm.kiom.re.kr/ontology/traditionalkoreanmedicine.rdf-xml.owl	1
134	//www.anzctr.org.au/actrn12608000411347.aspx	1
135	//www.anzctr.org.au/actrn12609000819224.aspx	1
136	//www.anzctr.org.au/actrn12610000135011.aspx	1
137	//www.bcshguidelines.com/bcsh_process/evidence_levels_and_grades_of_recommendation/43_grade.html	1
138	//www.clinicaltrials.gov/ct2/show/nct00158639	1
139	//www.clinicaltrials.gov/ct2/show/nct00895700	1
140	//www.clinicaltrials.gov/ct2/show/nct00962494	1
141	//www.clinicaltrials.gov/ct2/show/nct01084018	1
142	//www.clinicaltrials.gov/ct2/show/nct01236209	2
143	//www.clinicaltrials.gov/ct2/show/nct01296321	1
144	//www.clinicaltrials.gov/ct2/show/nct01715649	1
145	//www.clinicaltrials.gov/ct2/show/nct01913496	1
146	//www.clinicaltrials.gov/ct2/show/nct02114788	1
147	//www.controlled-trials.com/isrctn/pf/55651027	1
148	//www.controlled-trials.com/isrctn07752711	1
149	//www.controlled-trials.com/isrctn16823487	1
150	//www.controlled-trials.com/isrctn19739792	1
151	//www.controlled-trials.com/isrctn24529487	1
152	//www.controlled-trials.com/isrctn24735383	1
153	//www.controlled-trials.com/isrctn24874457	1
154	//www.controlled-trials.com/isrctn31070347	1
155	//www.controlled-trials.com/isrctn31586428/	1
156	//www.controlled-trials.com/isrctn35739639	2
157	//www.controlled-trials.com/isrctn39104853	1
158	//www.controlled-trials.com/isrctn41034162	1
159	//www.controlled-trials.com/isrctn42687923/	1
160	//www.controlled-trials.com/isrctn45178534	1
161	//www.controlled-trials.com/isrctn48134476	1
162	//www.controlled-trials.com/isrctn48473735	1
163	//www.controlled-trials.com/isrctn50512934/	1
164	//www.controlled-trials.com/isrctn55651027	1
165	//www.controlled-trials.com/isrctn57754429	1
166	//www.controlled-trials.com/isrctn61819220	1
167	//www.controlled-trials.com/isrctn69603913	1
168	//www.controlled-trials.com/isrctn75058295	1
169	//www.controlled-trials.com/isrctn76298775	1
170	//www.controlled-trials.com/isrctn76460837	1
171	//www.controlled-trials.com/isrctn77864351	1
172	//www.controlled-trials.com/isrctn79864465	1
173	//www.controlled-trials.com/isrctn82153174	1
174	//www.controlled-trials.com/isrctn90110503/isrctn90110503	1
175	//www.controlled-trials.com/isrctn91623132	1
176	//www.controlled-trials.com/isrctn91879928	1
177	//www.controlled-trials.com/isrctn92107365/	1
178	//www.controlled-trials.com/isrctn93702927	1
179	//www.controlled-trials.com/isrctn93903959/	1
180	//www.controlled-trials.com/isrctn96595458	1
181	//www.controlled-trials.com/isrctn98176068	1
182	//www.controlled-trials.com/isrctn98560867	1
183	//www.ensaiosclinicos.gov.br/rg/rbr-7yhr4w/	1
184	//www.gsk-clinicalstudyregister.com	1
185	//www.gsk-clinicalstudywww.gsk-clinicalstudyregister.com	1
186	//www.isrctn.com/isrctn56326375	1
187	//www.register.clinicaltrials.gov/	1
188	//www.strokecenter.org/	1
189	//www.umin.ac.jp/ctr/listj/	1
190	//www.umin.ac.jp/english/	1
191	/df	1
192	/fe3o4	1
193	/pa-ea	1
194	/pom	1
195	/π	1
196	0-8.0	2
197	0.00-0.18	2
198	0.00-0.92	1
199	0.002-0.397	1
200	0.01-0.43	1
201	0.01-0.86	1
202	0.02-16.34microgg	1
203	0.03-1.87	1
204	0.05-0.95	1
205	0.06-1.30	1
206	0.070-0.079	2
207	0.080-0.859	1
208	0.0899	1
209	0.09-0.29	2
210	0.09-0.99	2
211	0.1,0.2	1
212	0.10-0.60	2
213	0.10-1.00	1
214	0.11-0.21	1
215	0.12-3.72	1
216	0.13-0.60	1
217	0.15-0.71	1
218	0.16-0.62	3
219	0.16-3.4	1
220	0.17-0.79	1
221	0.18-1.2	1
222	0.18–0.86	1
223	0.2-9.2	1
224	0.21-0.55	3
225	0.22-2.48	1
226	0.22–0.91	1
227	0.23-0.45	2
228	0.24-0.31	1
229	0.253v	1
230	0.26-0.40	1
231	0.28-1.41	1
232	0.29-0.58	3
233	0.29-1.0	1
234	0.2w/cm	1
235	0.30-5.59	1
236	0.33-0.55	1
237	0.33-132.8	1
238	0.331-0.696	1
239	0.34-0.72	2
240	0.34-1.74	1
241	0.348v	1
242	0.35-1.45	1
243	0.36-0.61	2
244	0.36-0.62	2
245	0.36-0.86	1
246	0.37-1.81	1
247	0.38-0.66	7
248	0.38-0.71	3
249	0.38-0.99	1
250	0.39-0.80	3
251	0.39-84.1	1
252	0.396*age	1
253	0.3±0.02×10	1
254	0.41-1.88	1
255	0.41-1.91	2
256	0.42-2.69	1
257	0.43-1.47	1
258	0.43-2.00	1
259	0.44-0.70	1
260	0.451-0.620	1
261	0.46-0.63	1
262	0.46-1.25	1
263	0.46-1.262	1
264	0.46-1.70	1
265	0.46-2.43	1
266	0.468ch50	1
267	0.47-1.37	1
268	0.48-1.85	1
269	0.48–1.14	1
270	0.49-2.05	1
271	0.49-4.27	1
272	0.4p	1
273	0.50-1.45	3
274	0.50-2.58μghml	1
275	0.50-2.83	1
276	0.51-1.08	2
277	0.54-0.97	4
278	0.54-1.32	1
279	0.54-1.76	1
280	0.55-0.65	2
281	0.55-1.27	2
282	0.56-4.46	1
283	0.58-1.14	2
284	0.59-1.23	2
285	0.59-1.52	2
286	0.60-1.35	1
287	0.60-1.40	1
288	0.61-1.96	1
289	0.610-0.970	1
290	0.614-0.979	1
291	0.62-1.58	1
292	0.625-0.970	1
293	0.63-1.87	1
294	0.639-0.904	1
295	0.64-2.07	1
296	0.64-6.63	1
297	0.65-0.77	3
298	0.65-1.15	2
299	0.66-1.23	1
300	0.66-1.40	1
301	0.66-2.02	1
302	0.66-8.10	1
303	0.668-0.947	1
304	0.67-1.30	1
305	0.67-7.06	1
306	0.68-1.96	1
307	0.685min	1
308	0.69-1.32	1
309	0.6±0.05×10	1
310	0.7-1.91	1
311	0.71-1.17	3
312	0.71-3.25	1
313	0.71-3.94	1
314	0.72-1.28	6
315	0.7214	1
316	0.75-1.98	1
317	0.777-1.532	1
318	0.781×	1
319	0.79-0.98	8
320	0.80-1	1
321	0.80-3.20	1
322	0.82-	1
323	0.82-3.18	2
324	0.8232	1
325	0.824-0.904	1
326	0.83-11.7	1
327	0.84-0.90	4
328	0.84-1.59	1
329	0.85-1.15	4
330	0.86-1.003	1
331	0.87-1.16	1
332	0.87-1.57	1
333	0.88-1.85	1
334	0.88-1.98	2
335	0.88-2.10	1
336	0.89-1.38	2
337	0.89-11.01	1
338	0.9-18.0	1
339	0.9-2.9	4
340	0.905×10	1
341	0.91-2.61	1
342	0.92-1.2	1
343	0.93-2.33	1
344	0.94-4.08	1
345	0.95-1.43	4
346	0.95-13.68	1
347	0.96-5.61	1
348	0.960-0.976	1
349	0.98-1.81	4
350	0.98-2.24	1
351	0.98-3.39	1
352	0.984-0.992	1
353	0.988-0.995	1
354	0.99-2.63	1
355	0/109	1
356	0/17	8
357	0/73	3
358	0/82	3
359	0455	1
360	05.134	1
361	08:00-15:59	1
362	0:23-0:26	1
363	0:58-1:19	1
364	0ima	1
365	0·13-0·54	1
366	0·5-2·9	1
367	0·57-1·24	1
368	0·8-2·9	1
369	1+2	53
370	1+exp	5
371	1,2-butadiene	1
372	1,3,4-thiadiazolium-5-methylthio-	1
373	1,3-dimethylol-5,5-dimethylhydantoin	1
374	1,72	2
375	1-1	34
376	1-223	2
377	1-metylo-2-	1
378	1.0-34.9	1
379	1.0-83.3	1
380	1.00-1.34	2
381	1.00-1.58	3
382	1.01-2.36	1
383	1.01-2.39	1
384	1.01-2.49	2
385	1.01-2.73	2
386	1.01-3.059	1
387	1.01-3.81	1
388	1.011-1.063	1
389	1.02-103.95	1
390	1.02-13.81	1
391	1.02-2.69	1
392	1.022-1.082	1
393	1.024x	1
394	1.03-2.08	1
395	1.03-2.5	1
396	1.03-3.33	2
397	1.03-5.98	1
398	1.03-6.41	1
399	1.04-1.16	8
400	1.04-1.76	1
401	1.048-4.761	1
402	1.05-1.21	2
403	1.05-1.71	2
404	1.05-2.63	1
405	1.05-3.46	1
406	1.05-3.70	1
407	1.05-3.76	1
408	1.06-1.29	1
409	1.06-1.36	1
410	1.06-37.19	1
411	1.06-4.50	1
412	1.06-7.36	1
413	1.07-13.22	1
414	1.07-2.76	1
415	1.07-5.57	1
416	1.08-1.97	1
417	1.08-3.98	1
418	1.09-1.29	1
419	1.09-2.37	1
420	1.09-3.56	1
421	1.09-3.79	1
422	1.1-7.8	2
423	1.10-1.51	3
424	1.10-1.94	1
425	1.10-11.96	1
426	1.11-1.35	1
427	1.11-4.18	1
428	1.11-6.62	1
429	1.12-1.18/1.03-1.09	1
430	1.12-1.31	1
431	1.12-1.32	1
432	1.12-1.67	3
433	1.12-3.24	1
434	1.13-1.92	1
435	1.13-3.8	1
436	1.14-1.150	1
437	1.15-1.36	1
438	1.15-3.16	1
439	1.15/1.06	1
440	1.16-	2
441	1.16-7.73	1
442	1.17-1.64	1
443	1.17-132.3	1
444	1.18-1.82	2
445	1.18-2.33	1
446	1.18-5.94	1
447	1.18-6.97	1
448	1.19-8.26	1
449	1.2-10.2	1
450	1.20,3.71	1
451	1.201	3
452	1.21-2.74	1
453	1.21-2.80	1
454	1.21-5.8	1
455	1.22-2.19	1
456	1.25-1.59	1
457	1.26-2.09	1
458	1.26-200.00	1
459	1.26-24.72	1
460	1.26-3.16	2
461	1.26-6.52	1
462	1.27-1.63	1
463	1.27-2.88	1
464	1.27-3.10	1
465	1.27-52.50	1
466	1.28-1.56	1
467	1.28-4.89	1
468	1.28-6.19	1
469	1.29-1.69	1
470	1.29-8.12	1
471	1.3-10.9	2
472	1.3-30.7	2
473	1.3-6.8	2
474	1.3-7.80	1
475	1.3096-39.6802	1
476	1.31-1.53	1
477	1.31-2.93	1
478	1.31-2.96	1
479	1.32-1.55	1
480	1.35-1.61	2
481	1.36-2.02	1
482	1.36-6.96	1
483	1.37-1.62	1
484	1.38-14.5	1
485	1.383-3.109	1
486	1.39-1.64	1
487	1.4-3.6	3
488	1.40-1.66	1
489	1.40-5.58	1
490	1.41-1.85	1
491	1.41±1.55	1
492	1.43-12.82	1
493	1.43-2.79	1
494	1.43-3.90	1
495	1.49-8.03	1
496	1.49-fold	2
497	1.5-5.6	4
498	1.50-12.02	1
499	1.51-3.97	1
500	1.52-1.90	1
501	1.52-3.88	1
502	1.52-5.74	1
503	1.53-2.39	2
504	1.53-9.61	1
505	1.58-1.91	1
506	1.59-37.17	1
507	1.6-10.9	1
508	1.6-8.5	1
509	1.60-11.37	1
510	1.61-1.85	1
511	1.611	2
512	1.63-19.8	1
513	1.63-6.43	1
514	1.68-3.44	1
515	1.69-6.75	1
516	1.69-9.90	1
517	1.708-6.373	1
518	1.711	1
519	1.72-17.42	1
520	1.729-4.997	1
521	1.73-10.25	1
522	1.73-2.80	1
523	1.76-24.59	1
524	1.76-4.55	1
525	1.78-4.27	2
526	1.79-6.73	1
527	1.8-8.7	1
528	1.88-6.79	1
529	1.89-4.04	1
530	1.9-2-1	1
531	1.90-10.24	1
532	1.92-2.37	1
533	1.95-2.32	1
534	1.95-7.99	1
535	1.99/2	2
536	1/226	1
537	1/39	3
538	1/41	3
539	1/53	3
540	1/73	4
541	10.36-19.03	1
542	10.85-15.30	1
543	10.87-12.7	1
544	10/16	13
545	10/181	2
546	10/495	1
547	10/70	3
548	100/172	2
549	100/290	1
550	1009/1276	1
551	10215	1
552	104-432	1
553	105.7-108.6	1
554	1059-1068	1
555	106369	1
556	106‑126	2
557	107/415	1
558	107998	1
559	107·5	1
560	109-117	1
561	11,12-dhet	1
562	11,99	1
563	11.1-21.0	2
564	11.2-44.5	1
565	11.26±1.96	1
566	11.6-24.6	1
567	11.7-18.0	1
568	11.9-45.9	1
569	11.mpcwp	1
570	11/47	2
571	11/50	8
572	111.24	2
573	112.5j/cm	1
574	113.69	1
575	114.1-225.4	1
576	115/159	1
577	115/177	1
578	115·0	1
579	116.14ngg	1
580	118-517	1
581	118·2	1
582	119/732	1
583	12,30-di-aza-hepta-cyclo	1
584	12,420	1
585	12.7-60.2	1
586	12/107	1
587	12/165	1
588	12/178	2
589	12/273	1
590	123-37,553	1
591	126.64gycm	1
592	126/196	1
593	128.34	1
594	13*/-6	1
595	13.8-21.2	1
596	13/2591	1
597	13/34	3
598	13/74	2
599	13102-13113	1
600	132.63	1
601	132/989	1
602	134/151	1
603	135-418	1
604	135.7±10.9	1
605	136-143	1
606	1366.4	1
607	14.0±3.0	2
608	14/172	1
609	14/64	4
610	140/196	1
611	143/419	1
612	146/251	1
613	15-47	2
614	15.53-33.27	1
615	15/32	6
616	15/40	8
617	15/65	4
618	15/93	1
619	151.67	1
620	151.68	1
621	157/810	1
622	16.2-21.8	1
623	16.2-62.7	1
624	16/129	1
625	16/42	6
626	16/87	4
627	166-171	1
628	167/279	1
629	17/118	2
630	173491	2
631	177/196	1
632	178-183	1
633	17syn	3
634	18.0-45.0	1
635	18/81	2
636	180.02gycm	1
637	183,452	1
638	185.24-274.70	1
639	185/246	1
640	18:3	39
641	18hcrp	1
642	19.8-27.0	1
643	19/167	1
644	19/22	19
645	19/37	6
646	19/39	5
647	194:66	1
648	1966-97	2
649	198-205	1
650	199/242	2
651	1cm3	1
652	1·048	1
653	1·06-1·95	1
654	1·07-1·83	1
655	1·090	1
656	1·099	1
657	1·139	1
658	1·8-2·1	1
659	1·84	2
660	2',3'-c	1
661	2'-o-acetyldihydropenstemide	1
662	2+3	9
663	2-34	3
664	2-amino-2-	2
665	2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine	3
666	2-megapixel	1
667	2-methoxy-n-	1
668	2-o-methyl-l-chiro-inositol	1
669	2.04-5.07	1
670	2.04-8.77	1
671	2.07-98.28	1
672	2.07±0.98×10	1
673	2.1-5.7	1
674	2.10-2.93	1
675	2.11-5.32	1
676	2.1·10	1
677	2.246	2
678	2.25/month	1
679	2.2±2.7	1
680	2.33-2.38	1
681	2.37-5.98	1
682	2.398	1
683	2.39×10	1
684	2.43-42.35	1
685	2.44-7.41	1
686	2.4months	1
687	2.4±0.09	1
688	2.5-296.1	1
689	2.5-30.5	1
690	2.514-20.575	1
691	2.58±0.72×10	1
692	2.6-10.6	2
693	2.66-3.28	1
694	2.7-28.5	1
695	2.73-3.00	1
696	2.8-35	1
697	2.82-6.52	1
698	2.93-6.35	1
699	2.94-3.77	1
700	2.ae+prime	1
701	2/135	2
702	2/85	2
703	2/94	4
704	20.4-27.0	1
705	20/76/76/15	1
706	2006-001795-20	2
707	2008-000583-16	1
708	2008_06	1
709	2011-003243-21	1
710	2012-003343-29	1
711	2012-005511-11	1
712	203.54ngg	1
713	2066-2073	1
714	207.6	2
715	20:3	4
716	20:4	23
717	20:5	27
718	20°c/20°c	1
719	20·04	1
720	20·06	1
721	21,779	1
722	21.2-56.4	1
723	21.9±1.7kg/m	1
724	211.66	1
725	216/605	1
726	22.1-28.8	1
727	22.8-29.2	1
728	22/151	2
729	22/164	2
730	22/27	6
731	22/39	5
732	22/42	3
733	22/66	2
734	22:5	9
735	22:6	35
736	23/129	1
737	23/187	1
738	23/37	3
739	23/371	1
740	23/70	2
741	23/78	3
742	235-240	1
743	23·00	1
744	24,74	1
745	24.6pmol/l	1
746	24/454	1
747	243.9	2
748	2460-4665	1
749	25-169	1
750	25/66	3
751	252-396	1
752	252/274	2
753	256.2	2
754	26.1-102.1	1
755	26.9-48.1	1
756	26/108	1
757	26/174	1
758	2625ml	1
759	268.3	1
760	27/158	1
761	273.9	1
762	28,398	1
763	28.0-34.4	1
764	28.4±0.5×10	1
765	28/56	2
766	282/2615	1
767	29-160	1
768	29/586	1
769	29/69	3
770	2951-6609	1
771	2:02-2:14	1
772	2ehrz	3
773	2n	45
774	2p23-24	1
775	2·44	2
776	2π	1
777	3'-c-ethynylcytidine	1
778	3'-igh	3
779	3'-o-methyltaxifolin	1
780	3'ψβ	2
781	3,300,708	1
782	3,387	1
783	3,4-dhpea-eda	3
784	3,4-dimethyl-5,5-dioxidopyrazolo	2
785	3-methyl-4-	4
786	3-substituent	2
787	3.1-11.2	1
788	3.1-7.6	1
789	3.1-8.7	2
790	3.11±1.84×10	1
791	3.15-5.61	1
792	3.2-4.9	2
793	3.2h	3
794	3.3-64.8	1
795	3.3-8.8	2
796	3.4-16.5	1
797	3.4-19.2	1
798	3.42/month	1
799	3.5/3.7	1
800	3.532	3
801	3.552	1
802	3.683	2
803	3.88-9.29	1
804	3/155	1
805	3/163	1
806	3/234	1
807	3/28	7
808	3/39	9
809	3/45	14
810	3/56	3
811	30.51-62.30	1
812	301-621	1
813	308.35	1
814	30·23	1
815	31/29	3
816	31/36	6
817	31/46	6
818	312.8	1
819	32/37	8
820	326.15	1
821	33.2±1.1×10	1
822	33/47	3
823	333-46	1
824	33μg/kg/day	1
825	34,286	1
826	34.3-38.1	1
827	34/48	3
828	34/89	1
829	3487±978.5	1
830	349.9	1
831	35.6-57.8	1
832	35/48	3
833	35/73	2
834	352/1091	1
835	3569.2	1
836	36.35°c	1
837	36.3±5.4kg/m	1
838	36/111	2
839	36/190	1
840	36/547	1
841	37/37	2
842	370/429	1
843	372/mm	1
844	378.0	1
845	37±15hour	1
846	38.5-60.9	1
847	38/56	2
848	3808	2
849	39/56	6
850	391-3452	1
851	393.20	1
852	3:43-4:16	1
853	3cl	24
854	3pter	1
855	3xsta	2
856	3·28-9·29	1
857	4,24	1
858	4,4-dimethyl-2-	1
859	4,7	13
860	4-41	4
861	4-acetyl-3-	1
862	4-amino-2,2-bis	1
863	4-halogeno-n-	1
864	4-phenyl-1,2,4-triazole-3,5-dione	1
865	4.1-16	1
866	4.1-17.1	1
867	4.4/4.8	1
868	4.5/4.6	1
869	4.6±4.4pmoll	1
870	4.779	1
871	4.8-20.8	1
872	4.84-843.2	1
873	4.95-10.84	1
874	4/21	13
875	4/28	6
876	4/32	9
877	4/39	6
878	4/3π	2
879	4/58	5
880	4/63	3
881	4/83	2
882	4/89	5
883	4009	1
884	41.594l	1
885	41/10	1
886	41/190	1
887	41patients	1
888	42,591	1
889	42.22-	1
890	42/540	1
891	420/1,106	1
892	43.0-54.8	1
893	432/497	1
894	44,72	1
895	44/68	1
896	446.3	1
897	46.6±2.7×10	1
898	46/101	1
899	46/190	1
900	46/216	1
901	461-466	1
902	466.6	1
903	469/mm	1
904	48.2kpa	1
905	481/574	1
906	482.1	1
907	493-978	1
908	495-502	1
909	4:19-4:38	1
910	4·72	3
911	5,6,4'-trihydroxy-7,8-dimethoxyflavone	1
912	5.13-9.15	1
913	5.7-55.1	1
914	5.7-8.6	1
915	5.84×10	2
916	5.89-13.06	1
917	5/114	1
918	5/154	3
919	5/292	1
920	5/32	11
921	5/69	2
922	50-89mg/m	1
923	50.0-98.7	1
924	51.4-69.6	1
925	51/61	4
926	514c	1
927	52.5-71.5	1
928	522/f	1
929	52937	1
930	52±22	1
931	53.66gycm	1
932	54/495	1
933	55.57	1
934	55/169	1
935	55/186	1
936	5534201182098351	1
937	56.3-67.9	1
938	561.79	1
939	57/118	1
940	57/63	3
941	58.1±5.2×10	1
942	59.5-76.5	1
943	5a-5o	1
944	5s2,5f4	1
945	5u/ml	1
946	6-54	4
947	6.3-14.4	1
948	6.5-21.1	1
949	6.6±3.5×10	1
950	6.75m/s	1
951	6.97-11.21	1
952	6.97-9.40	1
953	62.15	2
954	63-92	1
955	63.7-97.0	2
956	633.6	1
957	637.6	1
958	64.2±6.5mlkg	1
959	642g	1
960	65.21	2
961	65.6-66.1	1
962	65/148	1
963	67,600	1
964	68.4-72.9	1
965	6878	1
966	7-eth-d	3
967	7-lsign	1
968	7-phenyl-7-	1
969	7.24×10	1
970	7.4-11.5	2
971	7.4-13.7	1
972	7.4-15.7	1
973	7.6-26.5	1
974	7/118	3
975	7/56	1
976	7/83	3
977	7/93	2
978	70/84	1
979	713-718	1
980	727-33	1
981	7293	1
982	73187232	1
983	732,009	1
984	75/234	2
985	75/76	5
986	754-762	1
987	76737502	1
988	77/84	1
989	7778	1
990	78/95	1
991	79.0±1.7×10	1
992	8,8'dimethyl-3,4,3',4'-dimethylenedioxy-7-oxo-2,7'cyclolignan	1
993	8-iso-pgf2	4
994	8.09/6.07	1
995	8.5-9.7	1
996	8.5±6.6×10	1
997	8.6-10.7	1
998	8.67-18.14	1
999	8.8-28.3	1
1000	8.83-15.28	1
1001	8/119	3
1002	8/153	3
1003	8/351	1
1004	8/52	4
1005	8/93	2
1006	80/206	1
1007	80gy	2
1008	81-207	1
1009	812-824	1
1010	82.914	1
1011	82/547	1
1012	830-844	1
1013	84.9-99.5	1
1014	86.6-102.3	1
1015	87.5±3.8×10	1
1016	87.7-165.8	1
1017	87.9-94.4	1
1018	87/284	1
1019	88.2-94.6	1
1020	88.27	1
1021	89.61	3
1022	9.3-22.0	1
1023	9.4-12.4	2
1024	9.5·10	1
1025	9.lvedp	1
1026	9/172	1
1027	9/31	9
1028	9/43	2
1029	92/171	1
1030	93.1-98.8	1
1031	93.4kpa	1
1032	93/255	1
1033	95/5/0.05	1
1034	973-981	1
1035	9gammat4/	1
1036	:18q21.1	1
1037	:18q23	1
1038	:21q22.1	1
1039	:3q12	1
1040	:beta-glucuronidase-reporter	1
1041	:egfp	1
1042	=0.986	2
1043	=1.91	2
1044	a-diet	1
1045	a-hypertensive	1
1046	a-receiving	1
1047	a.nelson	1
1048	a/ussr/77	1
1049	a293	2
1050	a49g	1
1051	a=8.4749	1
1052	a=fluorouracil-epirubicin-cyclophosphamide	1
1053	acr-n	7
1054	actrn12609000257268	1
1055	actrn12610000604000	1
1056	actrn12611001032943	1
1057	actrn12612001281886	1
1058	actrn12614000995673	1
1059	adolphs	1
1060	adp-fe	1
1061	agassiz	1
1062	agcl	5
1063	age=8.2	2
1064	aiai	1
1065	akinetic-dyskinetic	1
1066	alb:05	2
1067	albion:2005	1
1068	alcohol/drug-revised	1
1069	aldao	1
1070	algna/fe₃o₄	1
1071	alpha-bab	3
1072	altmann	1
1073	alvr	5
1074	alwar	1
1075	amalaki	4
1076	amd=-11.9	1
1077	amd=-8.1	1
1078	amerman	1
1079	amidon	1
1080	aml2	1
1081	anaconda®	1
1082	androsteredione	1
1083	anhedonia-asociality	3
1084	ant-moa	2
1085	anti-diphteria	1
1086	ao-vti	2
1087	aq*	1
1088	arg339gln	1
1089	arnarson	1
1090	asgaal	2
1091	asistencia	1
1092	auc0-12hr	3
1093	aunano	1
1094	aux-cc-857	1
1095	ay349182.1	1
1096	azetidin-2-one	2
1097	b2o3	7
1098	b2→b19	3
1099	barû	1
1100	baso	3
1101	baumstark	1
1102	bausch	43
1103	bazyluk	3
1104	behbehani	1
1105	beier	1
1106	bendall-lyon	1
1107	benz	12
1108	beta=1.84	1
1109	bi-arg/au	3
1110	bibhitaki	3
1111	biological/physical	1
1112	birrd	1
1113	bivm	2
1114	bluephaseg2	1
1115	blyth	1
1116	bmd-dr	4
1117	bmi=27-45kg/m	1
1118	bonnier	1
1119	bospa	1
1120	boyes	1
1121	brainerd	1
1122	breadsticks	3
1123	bronchitis/pneumonia/bronchopneumonia	1
1124	bu-phoban	2
1125	buckup	1
1126	bupo3h2	1
1127	butorphanol/saline	1
1128	c-bat	3
1129	c-g-g	2
1130	c.139delg	1
1131	c.1670-191c	1
1132	c.82g	2
1133	c.y.wu	2
1134	c/cm	2
1135	c000000146	1
1136	c10m	3
1137	c20:5	11
1138	c22:4	2
1139	c22:6	20
1140	c4h3o-cho	1
1141	c6h5cho	3
1142	ca4lao	1
1143	cacbtp=3.46	1
1144	cahsp25.99n	1
1145	cam:171:09	1
1146	camaguey:171:2009	1
1147	canestri	1
1148	carbamoyl	13
1149	cassagnau	3
1150	caucasian/white	3
1151	cd+	4
1152	cd004602	1
1153	cd31/cd34	1
1154	cd40lg	4
1155	cdsmp-plus-exercise	1
1156	ce-c	2
1157	cellulosomal	2
1158	cendres	1
1159	cfu-c	4
1160	chamisso	1
1161	chapso	5
1162	chictr-trc-11001614	1
1163	chictr-trc-12002174	1
1164	chictr-trc-12002718	1
1165	chictr-trc-13003594	1
1166	chictr-trc-13003661	1
1167	chictr-trc-14004720	1
1168	chilopoda	2
1169	chlorhexidine-metronidazole	1
1170	cholesterol-0-acyltransferase	1
1171	cichlidae	3
1172	circumferential-longitudinal	4
1173	cisd	8
1174	cl1	24
1175	cl3	11
1176	claparede	1
1177	classi	1
1178	clearfil-s3	1
1179	clinic-control	2
1180	clno	4
1181	cmax=18.50	1
1182	cmax=7.06	1
1183	cmax=77.7	1
1184	cmax=81.2	1
1185	cns-1	1
1186	cobamamide	4
1187	cofe₂o₄	5
1188	cold-fx	1
1189	coleus	11
1190	condylion-pogonion	1
1191	consort-spi	4
1192	control-fat	1
1193	control-placebo	3
1194	coo	38
1195	corbridge	1
1196	cordis/johnson	1
1197	cormac	1
1198	courneya	3
1199	cr-before	1
1200	crasilneck	1
1201	crp=21.7	1
1202	crs/kg	5
1203	cs3	25
1204	csf-p	11
1205	ct-control	2
1206	cuhk_cct00347	1
1207	cusimano	6
1208	cysts/mm	2
1209	d+	31
1210	d+6	2
1211	d-201-15004	1
1212	d9-phosphatidylcholine	1
1213	d9901	3
1214	d=-0.18	1
1215	d=0.11	3
1216	d=0.55	5
1217	dalz	2
1218	deci	4
1219	deffenbacher	1
1220	dehydration-placebo	1
1221	deltae	11
1222	deltag0	1
1223	deltandhb	1
1224	denzir	3
1225	dermaptera	2
1226	des-31,32-pi	3
1227	desenvolvimento	1
1228	diacylglyceroltransferase-1	1
1229	diane	7
1230	diaroot	1
1231	diarylpropionitrile	4
1232	dichelyne	2
1233	dihydro-artemisinin-piperaquine	1
1234	diolylphosphatidylethanolamine	1
1235	dione	7
1236	diphenylmethyl	4
1237	ditre	1
1238	diškus	3
1239	dly	4
1240	dmap	9
1241	dnad-devd-t	1
1242	do3a	4
1243	docetaxel+oxaliplatin	1
1244	docetaxel+oxaliplatin+cetuximab	1
1245	dosage/	1
1246	downtraining	1
1247	dpcpx	9
1248	drcf-dwarf	1
1249	drks00000443	1
1250	drks00003589	1
1251	drks00005223	1
1252	drug/drug	5
1253	duofluorid	1
1254	durafluor	1
1255	dxz	5
1256	dyne/cm	6
1257	dyz	3
1258	e'/	7
1259	e-flow	1
1260	e43893	1
1261	early-control	1
1262	ec1	4
1263	eco-s	2
1264	edronax-pharmacia	1
1265	een+glutamine	1
1266	egner	1
1267	elutes	11
1268	emm15	1
1269	enterobacteriales	3
1270	epivir®	1
1271	erkens	1
1272	es=-0.45	1
1273	es=0.39	1
1274	es=0.61	1
1275	essm	9
1276	etch+prime	1
1277	etch-and-rinse/rubber-dam	1
1278	ethyl-esters	4
1279	ethyl-sulfanyl	2
1280	ethylsulfanyl	2
1281	eu0.01	2
1282	eu0.03	2
1283	euphyodesmusphilippina	1
1284	ev=23	1
1285	evista	10
1286	evpm	4
1287	ex65	5
1288	exposure_long	1
1289	exposure_short	1
1290	extem	8
1291	extrastep	5
1292	eyewash	3
1293	f	6,657
1294	f-	37
1295	f-2	7
1296	f2	316
1297	f29	1
1298	f3/2	3
1299	f4	88
1300	f5/2→	2
1301	f6	23
1302	fact-h	6
1303	ferrocenyl	5
1304	figner	1
1305	fiss	2
1306	fj	50
1307	fk719875–fk759813	1
1308	flavanes	2
1309	fluarix	6
1310	foam-sclerotherapy	2
1311	folate-5	3
1312	forward-left	1
1313	fp100	4
1314	fs1	5
1315	f₂	10
1316	g-cem	9
1317	g-jstomy	4
1318	g-pre	1
1319	g.44369_50449dup	1
1320	g04	1
1321	g1-excavator	1
1322	g10-p	1
1323	g3p	28
1324	g6p	5
1325	g8-p	1
1326	galacto-oligosaccharide/fructo-oligosaccharide	1
1327	ganzfeld-electroretinography	1
1328	garaigordobil	1
1329	gaston	1
1330	gaudiano	1
1331	gauthier	2
1332	gbp/placebo	1
1333	gd2	10
1334	gdsand	5
1335	gdvo	1
1336	ge10	5
1337	ge12	1
1338	ge8as4	1
1339	ge8as6	1
1340	ginsenoside-rb1	1
1341	glrav-1	4
1342	gmfcs-e	5
1343	go-au/rusi	2
1344	gonion-menton	1
1345	goodacre	1
1346	goodman-kruskal	2
1347	gr-dlc	1
1348	gr-prp	2
1349	gr125743	3
1350	greuter	4
1351	ground-glass-opacity	1
1352	gstp1*b	1
1353	gt1	7
1354	gve/gva	2
1355	h-pyrazol-1-yl	1
1356	h2-bibta	2
1357	h45	1
1358	h65-h75	1
1359	ha8	1
1360	hager	1
1361	hales	1
1362	haritaki	6
1363	hba2-yialousa	1
1364	hcnt	3
1365	hdpd	4
1366	hemagglutinin-neuraminidase	6
1367	hemodynamic-obesity	1
1368	hepper	1
1369	hepta-cyclo	1
1370	herpv+qs-21	1
1371	hewitt	5
1372	hexahydro-2a,4a,6a-triaza-6b-phosphacyclopenta	1
1373	hexanic-leaf	2
1374	hfnu	9
1375	hif-1β	3
1376	high-sfa	10
1377	honorarium	7
1378	hotm	4
1379	hpv-cp8304	2
1380	hr=0.32	4
1381	hr=0.36	3
1382	hr=0.66	4
1383	hr=1.17	2
1384	hr=1.28	3
1385	ht=41.5	1
1386	humapen	9
1387	hydroxy-α-sanshool	4
1388	hyper-tg	1
1389	hυ	1
1390	i-control	1
1391	i-ing	1
1392	i13/2→	2
1393	i6	2
1394	i9/2	1
1395	ibα	5
1396	ie-3	2
1397	iib-positive	1
1398	iief-q9	4
1399	ilc1s	1
1400	imal	3
1401	immunofortis	5
1402	improvac®	4
1403	in-labeled-spio	1
1404	in-process	213
1405	in10	4
1406	industry=27.9	1
1407	inferior/+rv	1
1408	insbs	2
1409	intensive/indoor	1
1410	intermontana	1
1411	ipdasi	6
1412	irct2014050317534n1	1
1413	isaacowitz	1
1414	isobenzofuran-1	4
1415	isosurvival	9
1416	isrctn03000938	1
1417	isrctn05346737	1
1418	isrctn17436693	1
1419	isrctn21710246	1
1420	isrctn27312291	1
1421	isrctn32464251	1
1422	isrctn46295339	1
1423	isrctn61861069	1
1424	isrctn67338640	1
1425	isrctn79888843	2
1426	j/k	3
1427	j2	11
1428	janssen/j	1
1429	jingbie	1
1430	jjg	1
1431	jmc	1
1432	jmn–mn	4
1433	jmv	3
1434	k.d.hill	1
1435	k0	7
1436	k2hpo4	9
1437	kahneman	2
1438	kamiuntanto	1
1439	kapson	1
1440	kashy	1
1441	kbagd	4
1442	kellegren	1
1443	ki-vlok-63	1
1444	kibel	1
1445	kinact	3
1446	km1/3-gm3/17	1
1447	kt-cfp	3
1448	la	1
1449	l-d-	1
1450	l126c	1
1451	la/sa	3
1452	lactateinitial	2
1453	lallave	1
1454	laminaria-d	1
1455	large-for-ga	1
1456	lavmin	2
1457	lcos3060	1
1458	led-1500	3
1459	lehtinen	3
1460	lemée	1
1461	lgi-lgl	3
1462	lialda	2
1463	libbs	1
1464	life-h	5
1465	liquid/powder	1
1466	litten	2
1467	lmw-ha	4
1468	ln	742
1469	lncrp	2
1470	lns-p	4
1471	lo-asca	1
1472	lsli	2
1473	lta/vn	1
1474	lv-sd12-l	3
1475	lys751gln	2
1476	m/w	2
1477	m184c	1
1478	m3o-bc59	5
1479	m=2:1	1
1480	m=methylprednisolone	1
1481	ma-c	2
1482	male-87	1
1483	malkjovic	1
1484	massoud	1
1485	mb5	4
1486	mcconkie	1
1487	mcdas	3
1488	mcpyv-positive	1
1489	md-0.03	1
1490	mdfr	5
1491	me2	9
1492	medtronic-electrodes	1
1493	mef	74
1494	mehta	2
1495	meiser	3
1496	met35red	2
1497	mh5	2
1498	mhlw-h	2
1499	mi/mii	1
1500	micen	2
1501	mikrogen	2
1502	millaurine	1
1503	milosevic	1
1504	mim	46
1505	minicog	1
1506	mmancano	1
1507	mnse	3
1508	mocl	2
1509	moderate-f	1
1510	moderate-resistance-moderate-endurance	1
1511	mollosil	7
1512	monson	1
1513	mychen	1
1514	myricetin-3-o-arabinopyranoside	1
1515	myrtillin	2
1516	n-acetylglucosaminidase	2
1517	n-bu4n	3
1518	n-placebo	1
1519	n-stearoylethanolamine	1
1520	n6	15
1521	n=c	3
1522	na-hco3	1
1523	naal	2
1524	naemi	1
1525	nc-d	2
1526	nci-h1993/nci-h1915	2
1527	nct00049829	1
1528	nct00090103	1
1529	nct00151528	1
1530	nct00170352	1
1531	nct00197743	1
1532	nct00259012	1
1533	nct00272701	1
1534	nct00273663	1
1535	nct00319215	1
1536	nct00326001	1
1537	nct00326287	1
1538	nct00363896	1
1539	nct00374166	1
1540	nct00389597	2
1541	nct00400153	1
1542	nct00416741	2
1543	nct00467142	1
1544	nct00469872	1
1545	nct00473499	1
1546	nct00497549	1
1547	nct00528515	2
1548	nct00534235	1
1549	nct00537810	2
1550	nct00540462	1
1551	nct00542308	1
1552	nct00573560	1
1553	nct00607243	1
1554	nct00643448	1
1555	nct00667849	2
1556	nct00680056	1
1557	nct00747253	1
1558	nct00768755	1
1559	nct00792532	1
1560	nct00808496	1
1561	nct00833248	1
1562	nct00837811	1
1563	nct00875173	1
1564	nct00881894	1
1565	nct00902174	1
1566	nct00923403	1
1567	nct01044316	1
1568	nct01050517	1
1569	nct01059760	1
1570	nct01075633	1
1571	nct01078012	1
1572	nct01078818	1
1573	nct01097031	1
1574	nct01103258	1
1575	nct01112241	1
1576	nct01169454	1
1577	nct01182038	1
1578	nct01209364	1
1579	nct01254383	1
1580	nct01264406	1
1581	nct01286116	2
1582	nct01306175	1
1583	nct01329770	1
1584	nct01348048	1
1585	nct01389622	1
1586	nct01465685	1
1587	nct01478503	1
1588	nct01511341	1
1589	nct01593267	1
1590	nct01608048	1
1591	nct01609504	1
1592	nct01638962	1
1593	nct01641185	1
1594	nct01649973	1
1595	nct01650025	1
1596	nct01676987	1
1597	nct01697358	1
1598	nct01737281	1
1599	nct01737853	1
1600	nct01748058	1
1601	nct01761435	1
1602	nct01774669	1
1603	nct01781585	1
1604	nct01785316	1
1605	nct01802099	1
1606	nct01849172	1
1607	nct01929993	1
1608	nct01978392	1
1609	nct02021513	1
1610	nct02027194	1
1611	nct02028195	1
1612	nct02048553	1
1613	nct02124226	1
1614	nct02146053	1
1615	nct02151162	1
1616	nct02232945	1
1617	nct02236455	1
1618	ndpa-fe₃o₄	8
1619	neisvac-c	4
1620	neu	47
1621	neupogen	14
1622	neurolept-	1
1623	nevill	1
1624	ngt/low	1
1625	nhe1-5	1
1626	nhe6-9	1
1627	ni-sar	3
1628	nme3	2
1629	no-lsm-placebo	1
1630	nol-320	1
1631	nolac	3
1632	non-abc	3
1633	nonadecanol	1
1634	none.192	1
1635	nonhdl-e	2
1636	normal-pi	1
1637	normal/increased	1
1638	ntr1386	1
1639	ntr1806	1
1640	ntr567	1
1641	ntrtis	4
1642	nuk	1
1643	null-mutation	1
1644	nygaard	1
1645	n¹	3
1646	n→σ	1
1647	n⋯br	2
1648	o.7	1
1649	obstetricans	1
1650	oc-0.95	1
1651	och3	10
1652	octyl-p-methoxycinnamate	1
1653	ofirmev	3
1654	oh=3.7:1	1
1655	olineck	1
1656	olivers	1
1657	ons1200	4
1658	opp=	1
1659	or=0.04	1
1660	or=7.58	1
1661	or=8.91	1
1662	oregonin	1
1663	orf5	3
1664	orlinsky	1
1665	orr=3.32	1
1666	osa/mets	1
1667	osteobiol®	2
1668	ovary/peritoneal	1
1669	oxa-gel	2
1670	p-c	12
1671	p/	2
1672	p1.7-2,4	2
1673	p1/2	2
1674	p11	17
1675	p164	1
1676	p=p	1
1677	pactr201102000277177	1
1678	palmolein	2
1679	pao2/pao2	4
1680	papacárie®	2
1681	paroxetine-escitalopram	1
1682	patgl=docgl	2
1683	pax	10
1684	pb10	1
1685	pb12	4
1686	pb4	2
1687	pbu3	4
1688	pcdf	7
1689	pck-technique	1
1690	pd-negative	5
1691	pd142893	1
1692	pdrug	3
1693	pedop-au	3
1694	pentyl	6
1695	perruchet	1
1696	pglom	2
1697	pglu-leu-asn-phe-ser-pro-gly-trp	1
1698	ph-ponv	10
1699	pharmacometrics	5
1700	phenyl-c61-butyric-acid-methylester	1
1701	phet	24
1702	phosphinoyl	5
1703	phosphoaspartyl-pnkp	1
1704	pim1	9
1705	pizzo	1
1706	placebo/gbp	1
1707	placebo/placebo	13
1708	plasmacontrol	1
1709	plavix-sanofi	1
1710	plavix-sanofi-synthelabo	1
1711	pns_1	2
1712	poepp.	1
1713	polymethoxyethylacrylate	1
1714	polypeptide-o-beta-acetylglucosaminyltransferase	1
1715	polystyrenesulfonate	1
1716	poor-good	1
1717	portionsize	2
1718	post-t	1
1719	postbrochure	2
1720	postcard/letter/pamphlets	1
1721	pr2	5
1722	pre-fev	1
1723	pre-op	37
1724	prepropranolol	1
1725	pronamel	14
1726	proto	6
1727	protoaphin-fb	1
1728	psg/r	2
1729	pss-h	2
1730	pss/	1
1731	ptb-bo	2
1732	ptio	4
1733	py2	3
1734	pγ	1
1735	qam	11
1736	qbblind	1
1737	qbopen	1
1738	qlq-h	8
1739	quartermaster	2
1740	quinazolin-4-ylthio	2
1741	quoy	1
1742	qvar	13
1743	rad-i	1
1744	rebec	16
1745	redness/greenness	2
1746	regel	9
1747	rg-i	2
1748	rhinocort	2
1749	rho=0.27	2
1750	rifater	2
1751	rnapc2	1
1752	roelfsema	1
1753	rotational-	1
1754	rpap	6
1755	rpcec00000075	1
1756	rr=0.29	1
1757	rr=0.40	4
1758	rr=0.767	1
1759	rr=1.27	5
1760	rr=1.62	2
1761	rr=1.700	1
1762	rr=1.8	2
1763	rr=1.90	2
1764	rr=2.31	2
1765	rr=2.8	4
1766	rs1039084	1
1767	rs11694911	1
1768	rs4606	1
1769	rs9554316	1
1770	rs=0.17	1
1771	rt7ss	4
1772	rv-rag	3
1773	rv-strain	3
1774	rv/	5
1775	rvesp	11
1776	rvfw-s	3
1777	rvsrs	3
1778	s+/p+	1
1779	s0167-5273	1
1780	s125n	1
1781	s25-s33	1
1782	salen	8
1783	sand-blasting	1
1784	sanjappa	1
1785	sappanin-type	1
1786	saramuro	5
1787	sarocladium	1
1788	satogun	1
1789	sbf6	22
1790	sbst	7
1791	sc3n	10
1792	scch	1
1793	sch727965	2
1794	schoenmakers	1
1795	scolytinae	2
1796	sedentary-placebo	2
1797	self-anger	1
1798	self-moulded	2
1799	sens	11
1800	sensodyne	24
1801	sestamibi-1	5
1802	severity-adhd	1
1803	sevoflurane-lidocaine-tourniquet	1
1804	sf-6d/hui3	2
1805	sftpa1	1
1806	sham+saline	1
1807	shigyaku-to	2
1808	ship0804	1
1809	si-prp	5
1810	simde	8
1811	simplestep	4
1812	sistostenone	1
1813	sitagliptin-treatment	1
1814	sm1a	3
1815	smd=0.33	1
1816	smd=0.45	3
1817	smlat	1
1818	smz/tmp	3
1819	sn10	3
1820	soyang	3
1821	spapankvphsaanlplrf-nh2	1
1822	spirit-calling	1
1823	spotting/bleeding	1
1824	spti	21
1825	ss:03	1
1826	sse1/sse2	1
1827	st:04	2
1828	starns	1
1829	steane	1
1830	stimtg	9
1831	subcontinuous	1
1832	subfragment-1	3
1833	sulfinyl	6
1834	sulfinylbis	2
1835	szechtman	1
1836	sβ	6
1837	t-c	37
1838	t355c4326g-1293	1
1839	ta-nic	1
1840	tacd	3
1841	tadip	1
1842	tae-yang	3
1843	taeum	2
1844	tag:05	1
1845	taguasco:2005	1
1846	tdelay	3
1847	test-a	18
1848	test-b	12
1849	text-comprehension	1
1850	thiq	5
1851	tillman	1
1852	tn-tn-tn	1
1853	todaearly	1
1854	toegepast	1
1855	top-8	3
1856	top2alpha	1
1857	tosyl	2
1858	tr/pr	4
1859	trak	9
1860	trfm	2
1861	triazole-3-thiol	1
1862	trimethacrylate	3
1863	trois	3
1864	tsc22d3	1
1865	tvb	3
1866	tvie/tvia	1
1867	t₀	12
1868	u1111-1127-9390	1
1869	ubiquinone-oxidoreductase	1
1870	ud-fp-	2
1871	ultraminilaparotomy	1
1872	umin000005682	1
1873	umin000007833	1
1874	umin000009118	1
1875	uprima	2
1876	v0	40
1877	v90i	3
1878	valois	2
1879	variotin	1
1880	vbus	11
1881	vectibix	3
1882	ventriguard	2
1883	verum-	2
1884	victor-e3	1
1885	vlok	1
1886	vmu	5
1887	vos	3
1888	wall-motion-score-index	1
1889	wasmund	1
1890	wattakaka	1
1891	wca6h	5
1892	whitford	1
1893	windschitl	1
1894	wth	14
1895	wt×wt	1
1896	www.clinicaltrials.gov/ct2/show/nct01134705	1
1897	x1	28
1898	x16	3
1899	x2-	3
1900	x3	28
1901	xami	3
1902	xce	1
1903	xdy	6
1904	xeu	13
1905	xtb	5
1906	y=0.15e	1
1907	y=0.21e	1
1908	yb/tm	2
1909	yca₄o	2
1910	yce	2
1911	ych3nh3cl	1
1912	yellow-poplar	1
1913	yl	7
1914	yodt	1
1915	younger-placebo	1
1916	yttrium-scandium-gallium-garnet	6
1917	yttrium–aluminum–garnet	1
1918	yvo	3
1919	z-2-	2
1920	z-gly-pro-phe-4	1
1921	zentall	1
1922	zhdanov	1
1923	zno/zn	1
1924	znp-s-pcbd	1
1925	zolinza	4
1926	zyvox	2
1927	\|	27
1928	~380	1
1929	±0.01	4
1930	±0.23	3
1931	±0.92	2
1932	×3	13
1933	̇	2
1934	α-agonists	1
1935	αlac	4
1936	β1,3-galactosyltransferase‑4	1
1937	β=-2.4×10	1
1938	β=-2.82	1
1939	β=8.82	1
1940	δ	1,115
1941	δ6mwt	6
1942	δg	62
1943	δgwt	1
1944	δigf-1sds	2
1945	δiief-ef	1
1946	δn	5
1947	δr	23
1948	λmax	26
1949	ν1	10
1950	ν3	10
1951	π	133
1952	π*	21
1953	σ*	12
1954	σ0=881	1
1955	σ0=898	1
1956	σ0=921	1
1957	σ0=930	1
1958	σ0=973	1
1959	τ	307
1960	φ	66
1961	χ2=0.2	1
1962	χ2=4.2	1
1963	χ2=4.3	1
1964	ψ	19
1965	ω	141
1966	₅₀	4
1967	€2,397	1
1968	€222.30	1
1969	€3450	1
1970	€517.52	1
1971	€860.76	1
1972	∆	58
1973	∆g	9
1974	∆lvedv	2
1975	∆ppl	2
1976	∆ψ	3
1977	≤median	2
1978	≥3.78	1
1979	≥67.0°	1
1980	⩾75years	1

Words in suffix order

1	13*/-6	1
2	la	1
3	aq*	1
4	π*	21
5	σ*	12
6	d+	31
7	cd+	4
8	s+/p+	1
9	-24.51-	1
10	4,4-dimethyl-2-	1
11	1-metylo-2-	1
12	2-amino-2-	2
13	z-2-	2
14	42.22-	1
15	0.82-	1
16	x2-	3
17	4-acetyl-3-	1
18	3-methyl-4-	4
19	-3.4-	1
20	1.16-	2
21	7-phenyl-7-	1
22	-1.8-	1
23	-3178-	1
24	-2.98-	1
25	l-d-	1
26	f-	37
27	rotational-	1
28	verum-	2
29	4-halogeno-n-	1
30	2-methoxy-n-	1
31	1,3,4-thiadiazolium-5-methylthio-	1
32	ud-fp-	2
33	neurolept-	1
34	poepp.	1
35	e'/	7
36	//	15
37	//www.controlled-trials.com/isrctn42687923/	1
38	//www.controlled-trials.com/isrctn50512934/	1
39	9gammat4/	1
40	//www.controlled-trials.com/isrctn92107365/	1
41	//www.controlled-trials.com/isrctn31586428/	1
42	//www.controlled-trials.com/isrctn93903959/	1
43	dosage/	1
44	//www.strokecenter.org/	1
45	//www.umin.ac.jp/english/	1
46	//www.umin.ac.jp/ctr/listj/	1
47	p/	2
48	pss/	1
49	//www.register.clinicaltrials.gov/	1
50	rv/	5
51	//www.ensaiosclinicos.gov.br/rg/rbr-7yhr4w/	1
52	0.29-1.0	1
53	11.1-21.0	2
54	9.3-22.0	1
55	14.0±3.0	2
56	18.0-45.0	1
57	20.4-27.0	1
58	19.8-27.0	1
59	63.7-97.0	2
60	0-8.0	2
61	11.7-18.0	1
62	0.9-18.0	1
63	378.0	1
64	1.26-200.00	1
65	0.10-1.00	1
66	0.43-2.00	1
67	2.73-3.00	1
68	actrn12610000604000	1
69	-3.7-100	1
70	fp100	4
71	ons1200	4
72	led-1500	3
73	67,600	1
74	rr=1.700	1
75	//www.clinicaltrials.gov/ct2/show/nct00895700	1
76	23·00	1
77	0.88-2.10	1
78	1.27-3.10	1
79	0.66-8.10	1
80	41/10	1
81	//clinicaltrials.gov/ct2/show/nct01124110	1
82	157/810	1
83	nct00537810	2
84	pb10	1
85	ge10	5
86	in10	4
87	sn10	3
88	33.2±1.1×10	1
89	58.1±5.2×10	1
90	0.3±0.02×10	1
91	2.58±0.72×10	1
92	β=-2.4×10	1
93	7.24×10	1
94	3.11±1.84×10	1
95	5.84×10	2
96	28.4±0.5×10	1
97	6.6±3.5×10	1
98	0.6±0.05×10	1
99	0.905×10	1
100	8.5±6.6×10	1
101	79.0±1.7×10	1
102	46.6±2.7×10	1
103	87.5±3.8×10	1
104	2.07±0.98×10	1
105	2.39×10	1
106	2.1·10	1
107	9.5·10	1
108	2006-001795-20	2
109	+1.20	1
110	0.80-3.20	1
111	393.20	1
112	//www.controlled-trials.com/isrctn61819220	1
113	nol-320	1
114	12,420	1
115	//clinicaltrials.gov/ct2/show/nct01183520	1
116	0.451-0.620	1
117	chictr-trc-14004720	1
118	0.06-1.30	1
119	0.67-1.30	1
120	€222.30	1
121	30.51-62.30	1
122	10.85-15.30	1
123	σ0=930	1
124	0.26-0.40	1
125	rr=0.40	4
126	0.60-1.40	1
127	0.66-1.40	1
128	6.97-9.40	1
129	15/40	8
130	//clinicaltrials.gov/ct2/show/nct00729040	1
131	235-240	1
132	42/540	1
133	isrctn67338640	1
134	-10.50	1
135	1.27-52.50	1
136	1.06-4.50	1
137	cmax=18.50	1
138	11/50	8
139	1.14-1.150	1
140	€3450	1
141	0.468ch50	1
142	-0·50	2
143	0.10-0.60	2
144	0.13-0.60	1
145	lcos3060	1
146	29-160	1
147	nct00573560	1
148	nct01059760	1
149	0.44-0.70	1
150	0.46-1.70	1
151	1.05-3.70	1
152	185.24-274.70	1
153	10/70	3
154	23/70	2
155	//clinicaltrials.gov/show/nct01223170	1
156	//clinicaltrials.gov/ct2/show/nct00128570	1
157	nct01329770	1
158	0.610-0.970	1
159	0.625-0.970	1
160	0.39-0.80	3
161	1.21-2.80	1
162	1.73-2.80	1
163	1.3-7.80	1
164	~380	1
165	0.84-0.90	4
166	1.52-1.90	1
167	rr=1.90	2
168	1.43-3.90	1
169	-18.37±14.90	1
170	1.69-9.90	1
171	1·090	1
172	41/190	1
173	36/190	1
174	46/190	1
175	+0.0190	1
176	100/290	1
177	u1111-1127-9390	1
178	-2.890	2
179	deltag0	1
180	k0	7
181	//go.worldbank.org/d7sn0b8yu0	1
182	v0	40
183	115·0	1
184	0.80-1	1
185	1-1	34
186	1.9-2-1	1
187	diacylglyceroltransferase-1	1
188	sestamibi-1	5
189	isobenzofuran-1	4
190	cns-1	1
191	subfragment-1	3
192	glrav-1	4
193	6.5-21.1	1
194	:18q21.1	1
195	26.1-102.1	1
196	:21q22.1	1
197	ay349182.1	1
198	482.1	1
199	0.39-84.1	1
200	5.7-55.1	1
201	65.6-66.1	1
202	2.5-296.1	1
203	4.1-17.1	1
204	amd=-8.1	1
205	34.3-38.1	1
206	26.9-48.1	1
207	eu0.01	2
208	±0.01	4
209	-1.86/-1.01	1
210	0.89-11.01	1
211	nct00326001	1
212	46/101	1
213	1.201	3
214	-601	1
215	nct00272701	1
216	d9901	3
217	2012-005511-11	1
218	d=0.11	3
219	36/111	2
220	1.611	2
221	1.711	1
222	//www.controlled-trials.com/isrctn07752711	1
223	nct00837811	1
224	rs11694911	1
225	p11	17
226	2011-003243-21	1
227	herpv+qs-21	1
228	0.11-0.21	1
229	1.05-1.21	2
230	6.97-11.21	1
231	65.21	2
232	4/21	13
233	//www.clinicaltrials.gov/ct2/show/nct01296321	1
234	301-621	1
235	σ0=921	1
236	0.24-0.31	1
237	1.12-1.31	1
238	rr=2.31	2
239	9/31	9
240	nct01097031	1
241	4-41	4
242	0.28-1.41	1
243	1.03-6.41	1
244	2.44-7.41	1
245	1/41	3
246	nct01112241	1
247	nct01511341	1
248	nct00416741	2
249	1.10-1.51	3
250	22/151	2
251	134/151	1
252	146/251	1
253	isrctn32464251	1
254	8/351	1
255	//www.controlled-trials.com/isrctn77864351	1
256	5534201182098351	1
257	0.36-0.61	2
258	es=0.61	1
259	1.35-1.61	2
260	0.91-2.61	1
261	3.15-5.61	1
262	0.96-5.61	1
263	1.53-9.61	1
264	89.61	3
265	51/61	4
266	chictr-trc-13003661	1
267	1.048-4.761	1
268	0.15-0.71	1
269	0.38-0.71	3
270	1.05-1.71	2
271	1.20,3.71	1
272	166-171	1
273	92/171	1
274	23/371	1
275	0.37-1.81	1
276	0.98-1.81	4
277	1.01-3.81	1
278	1.02-13.81	1
279	18/81	2
280	//clinicaltrials.gov/show/nct00939081	1
281	10/181	2
282	nct01737281	1
283	σ0=881	1
284	973-981	1
285	0.22–0.91	1
286	0.41-1.91	2
287	0.7-1.91	1
288	1.58-1.91	1
289	=1.91	2
290	or=8.91	1
291	//clinicaltrials.gov/ct2/show/nct01950091	1
292	352/1091	1
293	+0.0191	1
294	//nct01452191	1
295	isrctn27312291	1
296	173491	2
297	42,591	1
298	13/2591	1
299	m=2:1	1
300	oh=3.7:1	1
301	pns_1	2
302	sftpa1	1
303	ginsenoside-rb1	1
304	ec1	4
305	cl1	24
306	pim1	9
307	irct2014050317534n1	1
308	fs1	5
309	gt1	7
310	x1	28
311	1·8-2·1	1
312	ν1	10
313	1+2	53
314	f-2	7
315	0.1,0.2	1
316	1.2-10.2	1
317	12.7-60.2	1
318	χ2=0.2	1
319	0.92-1.2	1
320	0.18-1.2	1
321	3.1-11.2	1
322	13.8-21.2	1
323	cmax=81.2	1
324	-17.7+/-2.2	1
325	4.84-843.2	1
326	χ2=4.2	1
327	256.2	2
328	-10.0+/-8.2	1
329	age=8.2	2
330	0.2-9.2	1
331	3.4-19.2	1
332	22.8-29.2	1
333	3569.2	1
334	p1/2	2
335	f3/2	3
336	1.99/2	2
337	i9/2	1
338	1.36-2.02	1
339	0.66-2.02	1
340	1.50-12.02	1
341	495-502	1
342	76737502	1
343	cd004602	1
344	1.3096-39.6802	1
345	.97-1.12	1
346	-31.12	1
347	1.29-8.12	1
348	nct01078012	1
349	nct00259012	1
350	//clinicaltrials.gov/ct2/show/nct00169312	2
351	-0.512	5
352	pb12	4
353	ge12	1
354	:3q12	1
355	1.07-13.22	1
356	19/22	19
357	//clinicaltrials.gov/ct2/show/nct00794222	1
358	nct01389622	1
359	52±22	1
360	hr=0.32	4
361	1.12-1.32	1
362	0.54-1.32	1
363	0.69-1.32	1
364	1.95-2.32	1
365	orr=3.32	1
366	2.11-5.32	1
367	4/32	9
368	5/32	11
369	15/32	6
370	//www.controlled-trials.com/isrctn91623132	1
371	73187232	1
372	0.8232	1
373	104-432	1
374	0.777-1.532	1
375	3.532	3
376	nct00792532	1
377	119/732	1
378	1.72-17.42	1
379	22/42	3
380	16/42	6
381	//nct01702142	1
382	nct00467142	1
383	199/242	2
384	0.59-1.52	2
385	2.82-6.52	1
386	1.26-6.52	1
387	€517.52	1
388	8/52	4
389	nct00170352	1
390	183,452	1
391	391-3452	1
392	3.552	1
393	0.16-0.62	3
394	0.36-0.62	2
395	1.37-1.62	1
396	rr=1.62	2
397	1.11-6.62	1
398	nct02151162	1
399	//www.controlled-trials.com/isrctn41034162	1
400	0.46-1.262	1
401	nct00540462	1
402	754-762	1
403	nct01638962	1
404	1,72	2
405	44,72	1
406	0.34-0.72	2
407	0.12-3.72	1
408	1.26-24.72	1
409	100/172	2
410	14/172	1
411	9/172	1
412	nct01849172	1
413	nct00469872	1
414	4·72	3
415	1.18-1.82	2
416	β=-2.82	1
417	1.43-12.82	1
418	β=8.82	1
419	0/82	3
420	1.022-1.082	1
421	umin000005682	1
422	63-92	1
423	0.00-0.92	1
424	±0.92	2
425	1.13-1.92	1
426	none.192	1
427	5/292	1
428	nct01978392	1
429	//clinicaltrials.gov/ct2/show/nct01415492	1
430	//www.controlled-trials.com/isrctn19739792	1
431	0.984-0.992	1
432	rnapc2	1
433	gd2	10
434	me2	9
435	sse1/sse2	1
436	f2	316
437	8-iso-pgf2	4
438	bluephaseg2	1
439	bupo3h2	1
440	spapankvphsaanlplrf-nh2	1
441	j2	11
442	aml2	1
443	+h2o2	1
444	pao2/pao2	4
445	pr2	5
446	py2	3
447	118·2	1
448	2+3	9
449	ie-3	2
450	86.6-102.3	1
451	1.17-132.3	1
452	1.0-83.3	1
453	χ2=4.3	1
454	446.3	1
455	8.8-28.3	1
456	268.3	1
457	md-0.03	1
458	eu0.03	2
459	1.49-8.03	1
460	10.36-19.03	1
461	0.86-1.003	1
462	nct00090103	1
463	//clinicaltrials.gov/ct2/show/nct01295203	1
464	nct00923403	1
465	//www.controlled-trials.com/isrctn90110503/isrctn90110503	1
466	nct01478503	1
467	ss:03	1
468	13102-13113	1
469	nct02021513	1
470	fk719875–fk759813	1
471	//www.controlled-trials.com/isrctn69603913	1
472	±0.23	3
473	0.66-1.23	1
474	0.59-1.23	2
475	1-223	2
476	drks00005223	1
477	ev=23	1
478	:18q23	1
479	30·23	1
480	727-33	1
481	smd=0.33	1
482	0.93-2.33	1
483	1.18-2.33	1
484	1.03-3.33	2
485	nct01075633	1
486	umin000007833	1
487	s25-s33	1
488	0.01-0.43	1
489	0.95-1.43	4
490	-6.52+/-11.43	1
491	0.46-2.43	1
492	1.63-6.43	1
493	9/43	2
494	136-143	1
495	nct00607243	1
496	-0.643-8.443	1
497	drks00000443	1
498	gr125743	3
499	nct00197743	1
500	isrctn79888843	2
501	actrn12611001032943	1
502	1.31-1.53	1
503	1/53	3
504	nct02146053	1
505	8/153	3
506	nct00400153	1
507	//clinicaltrials.gov/ct2/show/nct01293253	1
508	nct00747253	1
509	123-37,553	1
510	nct02048553	1
511	//www.controlled-trials.com/isrctn39104853	1
512	nct01737853	1
513	ki-vlok-63	1
514	0.46-0.63	1
515	1.27-1.63	1
516	1.05-2.63	1
517	0.99-2.63	1
518	132.63	1
519	-15.63	1
520	0.64-6.63	1
521	4/63	3
522	57/63	3
523	1.011-1.063	1
524	3/163	1
525	nct00273663	1
526	1.01-2.73	2
527	1.79-6.73	1
528	1.16-7.73	1
529	-8.95±8.73	1
530	0/73	3
531	1/73	4
532	35/73	2
533	2066-2073	1
534	nct00875173	1
535	12/273	1
536	s0167-5273	1
537	1.708-6.373	1
538	actrn12614000995673	1
539	nct01649973	1
540	σ0=973	1
541	0.50-2.83	1
542	4/83	2
543	7/83	3
544	178-183	1
545	//clinicaltrials.gov/ct2/show/nct00214383	1
546	nct01254383	1
547	//www.controlled-trials.com/isrctn24735383	1
548	-2.583	2
549	3.683	2
550	1·07-1·83	1
551	-5·83	1
552	-121.93	1
553	2.10-2.93	1
554	1.31-2.93	1
555	15/93	1
556	7/93	2
557	8/93	2
558	t355c4326g-1293	1
559	7293	1
560	a293	2
561	isrctn17436693	1
562	pd142893	1
563	e43893	1
564	nct01929993	1
565	20:3	4
566	18:3	39
567	tsc22d3	1
568	victor-e3	1
569	nme3	2
570	och3	10
571	sf-6d/hui3	2
572	cl3	11
573	1cm3	1
574	b2o3	7
575	na-hco3	1
576	clearfil-s3	1
577	cs3	25
578	pbu3	4
579	x3	28
580	×3	13
581	ν3	10
582	6/4	1
583	p1.7-2,4	2
584	-93/-4	1
585	z-gly-pro-phe-4	1
586	9.4-12.4	2
587	0.16-3.4	1
588	6.3-14.4	1
589	28.0-34.4	1
590	87.9-94.4	1
591	114.1-225.4	1
592	-385.4	1
593	21.2-56.4	1
594	1366.4	1
595	or=0.04	1
596	1.89-4.04	1
597	d-201-15004	1
598	hpv-cp8304	2
599	nct01609504	1
600	ship0804	1
601	0.824-0.904	1
602	0.639-0.904	1
603	st:04	2
604	g04	1
605	20·04	1
606	-0.06-0.14	1
607	0.58-1.14	2
608	0.48–1.14	1
609	8.67-18.14	1
610	5/114	1
611	0.7214	1
612	chictr-trc-11001614	1
613	82.914	1
614	2:02-2:14	1
615	4,24	1
616	2p23-24	1
617	1.90-10.24	1
618	111.24	2
619	0.98-2.24	1
620	1.12-3.24	1
621	812-824	1
622	0·57-1·24	1
623	2-34	3
624	1.00-1.34	2
625	128.34	1
626	13/34	3
627	05.134	1
628	3/234	1
629	75/234	2
630	//www.controlled-trials.com/isrctn45178534	1
631	cd31/cd34	1
632	1.68-3.44	1
633	-€244	1
634	830-844	1
635	//clinicaltrials.gov/show/nct01013844	1
636	2·44	2
637	6-54	4
638	-1.32+0.54	1
639	5/154	3
640	24/454	1
641	nct01169454	1
642	0·13-0·54	1
643	1.17-1.64	1
644	1.39-1.64	1
645	14/64	4
646	22/164	2
647	p164	1
648	//clinicaltrials.gov/ct2/show/nct00992264	2
649	nct01209364	1
650	//clinicaltrials.gov/ct2/show/nct01331564	1
651	24,74	1
652	0.34-1.74	1
653	1.21-2.74	1
654	-11.29±3.74	1
655	1.52-5.74	1
656	13/74	2
657	26/174	1
658	chictr-trc-12002174	1
659	nct00902174	1
660	//www.controlled-trials.com/isrctn82153174	1
661	252/274	2
662	481/574	1
663	//clinicaltrials.gov/ct2/show/nct00159874	1
664	//clinicaltrials.gov/ct2/show/nct00220974	1
665	4.95-10.84	1
666	beta=1.84	1
667	-23.84	1
668	70/84	1
669	77/84	1
670	rs1039084	1
671	87/284	1
672	1·84	2
673	1.10-1.94	1
674	0.71-3.94	1
675	1.18-5.94	1
676	2/94	4
677	nct02027194	1
678	//www.clinicaltrials.gov/ct2/show/nct00962494	1
679	chictr-trc-13003594	1
680	nct00881894	1
681	20:4	23
682	c22:4	2
683	pb4	2
684	f4	88
685	5s2,5f4	1
686	/fe3o4	1
687	k2hpo4	9
688	ge8as4	1
689	β1,3-galactosyltransferase‑4	1
690	nhe1-5	1
691	folate-5	3
692	2.5-30.5	1
693	7.4-11.5	2
694	ht=41.5	1
695	52.5-71.5	1
696	1.03-2.5	1
697	1.38-14.5	1
698	11.2-44.5	1
699	3.4-16.5	1
700	7.6-26.5	1
701	59.5-76.5	1
702	1.6-8.5	1
703	2.7-28.5	1
704	3487±978.5	1
705	84.9-99.5	1
706	-4.14-0.05	1
707	95/5/0.05	1
708	0.49-2.05	1
709	albion:2005	1
710	taguasco:2005	1
711	198-205	1
712	-605	1
713	216/605	1
714	www.clinicaltrials.gov/ct2/show/nct01134705	1
715	alb:05	2
716	tag:05	1
717	0.65-1.15	2
718	0.85-1.15	4
719	62.15	2
720	-16.15	1
721	326.15	1
722	5.13-9.15	1
723	20/76/76/15	1
724	10215	1
725	nct00319215	1
726	//clinicaltrials.gov/show/nct00783315	1
727	107/415	1
728	nct00528515	2
729	282/2615	1
730	nci-h1993/nci-h1915	2
731	emm15	1
732	1.73-10.25	1
733	0.46-1.25	1
734	0.71-3.25	1
735	nct01650025	1
736	//clinicaltrials.gov/show/nct00816725	1
737	2.8-35	1
738	0.60-1.35	1
739	1.11-1.35	1
740	2.43-42.35	1
741	2.93-6.35	1
742	308.35	1
743	2/135	2
744	nct00534235	1
745	nct01761435	1
746	//clinicaltrials.gov/ct2/show/nct01744535	1
747	//www.controlled-trials.com/isrctn48473735	1
748	0.23-0.45	2
749	es=-0.45	1
750	smd=0.45	3
751	0.50-1.45	3
752	0.35-1.45	1
753	3/45	14
754	nct02232945	1
755	h45	1
756	.27-.55	1
757	0.21-0.55	3
758	0.33-0.55	1
759	d=0.55	5
760	1.32-1.55	1
761	1.41±1.55	1
762	1.76-4.55	1
763	3/155	1
764	93/255	1
765	//clinicaltrials.gov/ct2/show/nct01139255	1
766	0455	1
767	nct02236455	1
768	nct00768755	1
769	0.55-0.65	2
770	15/65	4
771	12/165	1
772	//www.controlled-trials.com/isrctn79864465	1
773	2460-4665	1
774	sch727965	2
775	ex65	5
776	-€65	1
777	-34.75	1
778	1.69-6.75	1
779	rpcec00000075	1
780	nct01306175	1
781	//www.isrctn.com/isrctn56326375	1
782	2.514-20.575	1
783	//controlled-trials.com/isrctn25619675	1
784	//www.controlled-trials.com/isrctn76298775	1
785	h65-h75	1
786	1.41-1.85	1
787	1.61-1.85	1
788	0.48-1.85	1
789	0.88-1.85	1
790	2/85	2
791	nct01641185	1
792	//clinicaltrials.gov/show/nct00987285	1
793	//clinicaltrials.gov/ct2/show/nct02080585	1
794	nct01781585	1
795	nct01465685	1
796	//clinicaltrials.gov/ct2/show/nct00751985	1
797	0.05-0.95	1
798	oc-0.95	1
799	1.02-103.95	1
800	78/95	1
801	.030-.095	1
802	nct02028195	1
803	//www.controlled-trials.com/isrctn75058295	1
804	10/495	1
805	54/495	1
806	//clinicaltrials.gov/ct2/show/nct00912795	1
807	0.988-0.995	1
808	1·06-1·95	1
809	20:5	27
810	c20:5	11
811	22:5	9
812	mb5	4
813	orf5	3
814	mh5	2
815	107·5	1
816	d+6	2
817	2.6-10.6	2
818	1.4-3.6	3
819	633.6	1
820	4.5/4.6	1
821	11.6-24.6	1
822	88.2-94.6	1
823	1.5-5.6	4
824	466.6	1
825	3.1-7.6	1
826	207.6	2
827	637.6	1
828	5.7-8.6	1
829	105.7-108.6	1
830	51.4-69.6	1
831	1.15/1.06	1
832	5.89-13.06	1
833	0.67-7.06	1
834	cmax=7.06	1
835	420/1,106	1
836	80/206	1
837	nct01264406	1
838	rs4606	1
839	ntr1806	1
840	2008_06	1
841	20·06	1
842	4.1-16	1
843	2008-000583-16	1
844	1.04-1.16	8
845	0.87-1.16	1
846	1.15-3.16	1
847	1.26-3.16	2
848	10/16	13
849	nct01286116	2
850	46/216	1
851	nct01044316	1
852	rs9554316	1
853	nct01785316	1
854	3:43-4:16	1
855	x16	3
856	1.19-8.26	1
857	106‑126	2
858	1/226	1
859	nct02124226	1
860	0:23-0:26	1
861	hr=0.36	3
862	1.15-1.36	1
863	1.06-1.36	1
864	1.01-2.36	1
865	1.06-7.36	1
866	31/36	6
867	333-46	1
868	1.05-3.46	1
869	cacbtp=3.46	1
870	0.56-4.46	1
871	31/46	6
872	c000000146	1
873	2.246	2
874	185/246	1
875	isrctn21710246	1
876	1.28-1.56	1
877	1.09-3.56	1
878	3/56	3
879	7/56	1
880	28/56	2
881	38/56	2
882	39/56	6
883	nct00680056	1
884	0.38-0.66	7
885	hr=0.66	4
886	1.40-1.66	1
887	211.66	1
888	+2.66	1
889	22/66	2
890	25/66	3
891	nct00374166	1
892	461-466	1
893	194:66	1
894	€860.76	1
895	1.04-1.76	1
896	0.54-1.76	1
897	1.07-2.76	1
898	1.05-3.76	1
899	75/76	5
900	1009/1276	1
901	//www.controlled-trials.com/isrctn48134476	1
902	0.960-0.976	1
903	0.01-0.86	1
904	0.36-0.86	1
905	0.18–0.86	1
906	55/186	1
907	34,286	1
908	//clinicaltrials.gov/ct2/show/nct01430286	1
909	ntr1386	1
910	29/586	1
911	//clinicaltrials.gov/ct2/show/nct00721786	2
912	actrn12612001281886	1
913	=0.986	2
914	0.61-1.96	1
915	0.68-1.96	1
916	1.10-11.96	1
917	11.26±1.96	1
918	1.31-2.96	1
919	1.36-6.96	1
920	140/196	1
921	126/196	1
922	177/196	1
923	252-396	1
924	//www.clinicaltrials.gov/ct2/show/nct01913496	1
925	nct00808496	1
926	0.331-0.696	1
927	nct00363896	1
928	22:6	35
929	c22:6	20
930	f6	23
931	sbf6	22
932	i6	2
933	n6	15
934	ge8as6	1
935	4,7	13
936	8.6-10.7	1
937	1.3-30.7	2
938	0.83-11.7	1
939	crp=21.7	1
940	10.87-12.7	1
941	16.2-62.7	1
942	2.2±2.7	1
943	3.5/3.7	1
944	7.4-13.7	1
945	2.1-5.7	1
946	7.4-15.7	1
947	cmax=77.7	1
948	3.1-8.7	2
949	1.8-8.7	1
950	50.0-98.7	1
951	8.5-9.7	1
952	o.7	1
953	0.64-2.07	1
954	2.04-5.07	1
955	8.09/6.07	1
956	12/107	1
957	81-207	1
958	//clinicaltrials.gov/ct2/show/nct00792207	1
959	-0.307	2
960	rs=0.17	1
961	0.71-1.17	3
962	hr=1.17	2
963	1.59-37.17	1
964	0/17	8
965	km1/3-gm3/17	1
966	109-117	1
967	//clinicaltrials.gov/ct2/show/nct01465217	1
968	118-517	1
969	nct01050517	1
970	//clinicaltrials.gov/show/nct01683617	1
971	rho=0.27	2
972	0.55-1.27	2
973	rr=1.27	5
974	15.53-33.27	1
975	1.78-4.27	2
976	0.49-4.27	1
977	88.27	1
978	22/27	6
979	//www.controlled-trials.com/isrctn/pf/55651027	1
980	//www.controlled-trials.com/isrctn55651027	1
981	//www.controlled-trials.com/isrctn93702927	1
982	0.47-1.37	1
983	1.60-11.37	1
984	1.92-2.37	1
985	1.09-2.37	1
986	32/37	8
987	23/37	3
988	37/37	2
989	19/37	6
990	isrctn05346737	1
991	//www.controlled-trials.com/isrctn76460837	1
992	52937	1
993	15-47	2
994	0.43-1.47	1
995	11/47	2
996	33/47	3
997	cuhk_cct00347	1
998	//www.controlled-trials.com/isrctn31070347	1
999	82/547	1
1000	36/547	1
1001	0.668-0.947	1
1002	0.87-1.57	1
1003	1.07-5.57	1
1004	55.57	1
1005	//www.controlled-trials.com/isrctn24874457	1
1006	aux-cc-857	1
1007	1.12-1.67	3
1008	151.67	1
1009	19/167	1
1010	nct01593267	1
1011	ntr567	1
1012	rr=0.767	1
1013	//www.controlled-trials.com/isrctn98560867	1
1014	0.65-0.77	3
1015	2.94-3.77	1
1016	2.04-8.77	1
1017	a/ussr/77	1
1018	115/177	1
1019	pactr201102000277177	1
1020	//clinicaltrials.gov/show/nct00885677	1
1021	-50977	1
1022	male-87	1
1023	0.03-1.87	1
1024	0.63-1.87	1
1025	16/87	4
1026	23/187	1
1027	nct00326287	1
1028	3,387	1
1029	//www.controlled-trials.com/isrctn16823487	1
1030	//www.controlled-trials.com/isrctn24529487	1
1031	nct01676987	1
1032	1966-97	2
1033	0.54-0.97	4
1034	1.08-1.97	1
1035	1.51-3.97	1
1036	1.18-6.97	1
1037	//iscrtn64669297	1
1038	€2,397	1
1039	0.002-0.397	1
1040	432/497	1
1041	nct00389597	2
1042	1.729-4.997	1
1043	top-8	3
1044	4.8-20.8	1
1045	16.2-21.8	1
1046	rr=1.8	2
1047	312.8	1
1048	0.33-132.8	1
1049	rr=2.8	4
1050	1.13-3.8	1
1051	4.4/4.8	1
1052	43.0-54.8	1
1053	3.3-64.8	1
1054	1.21-5.8	1
1055	87.7-165.8	1
1056	1.3-6.8	2
1057	1.1-7.8	2
1058	35.6-57.8	1
1059	3.3-8.8	2
1060	22.1-28.8	1
1061	93.1-98.8	1
1062	1.63-19.8	1
1063	0.51-1.08	2
1064	1.03-2.08	1
1065	0.94-4.08	1
1066	26/108	1
1067	//clinicaltrials.gov/ct2/show/nct00377208	1
1068	nct00542308	1
1069	3,300,708	1
1070	3808	2
1071	0.00-0.18	2
1072	d=-0.18	1
1073	0.82-3.18	2
1074	1.11-4.18	1
1075	//www.clinicaltrials.gov/ct2/show/nct01084018	1
1076	//clinicaltrials.gov/ct2/show/nct00694018	1
1077	7/118	3
1078	17/118	2
1079	57/118	1
1080	umin000009118	1
1081	135-418	1
1082	713-718	1
1083	chictr-trc-12002718	1
1084	nct01078818	1
1085	0.72-1.28	6
1086	hr=1.28	3
1087	2.66-3.28	1
1088	8.83-15.28	1
1089	2.07-98.28	1
1090	3/28	7
1091	4/28	6
1092	nct00151528	1
1093	//clinicaltrials.gov/ct2/show/nct00797628	1
1094	//www.controlled-trials.com/isrctn91879928	1
1095	0.89-1.38	2
1096	2.33-2.38	1
1097	nct01182038	1
1098	isrctn03000938	1
1099	4:19-4:38	1
1100	0.22-2.48	1
1101	34/48	3
1102	35/48	3
1103	nct01608048	1
1104	nct01348048	1
1105	1·048	1
1106	65/148	1
1107	nct00833248	1
1108	nct00643448	1
1109	0.29-0.58	3
1110	1.00-1.58	3
1111	0.62-1.58	1
1112	1.40-5.58	1
1113	or=7.58	1
1114	4/58	5
1115	nct01748058	1
1116	27/158	1
1117	nct01103258	1
1118	nct01697358	1
1119	//www.controlled-trials.com/isrctn96595458	1
1120	//clinicaltrials.gov/ct2/show/nct00710658	1
1121	.18-.68	1
1122	151.68	1
1123	0.95-13.68	1
1124	44/68	1
1125	1059-1068	1
1126	//www.controlled-trials.com/isrctn98176068	1
1127	actrn12609000257268	1
1128	//clinicaltrials.gov/show/nct01759368	1
1129	≥3.78	1
1130	23/78	3
1131	12/178	2
1132	7778	1
1133	6878	1
1134	493-978	1
1135	0.41-1.88	1
1136	1.27-2.88	1
1137	1.52-3.88	1
1138	//www.clinicaltrials.gov/ct2/show/nct02114788	1
1139	0.79-0.98	8
1140	0.75-1.98	1
1141	0.88-1.98	2
1142	1.08-3.98	1
1143	1.03-5.98	1
1144	2.37-5.98	1
1145	28,398	1
1146	2.398	1
1147	σ0=898	1
1148	107998	1
1149	ha8	1
1150	nhe6-9	1
1151	1.3-10.9	2
1152	1.6-10.9	1
1153	135.7±10.9	1
1154	38.5-60.9	1
1155	amd=-11.9	1
1156	0.9-2.9	4
1157	68.4-72.9	1
1158	243.9	2
1159	273.9	1
1160	3.2-4.9	2
1161	1.0-34.9	1
1162	11.9-45.9	1
1163	industry=27.9	1
1164	56.3-67.9	1
1165	349.9	1
1166	2.4±0.09	1
1167	1.12-1.18/1.03-1.09	1
1168	1.26-2.09	1
1169	732,009	1
1170	//clinicaltrials.gov/show/nct00971009	1
1171	//clinicaltrials.gov/ct2/show/nct00282009	1
1172	//clinicaltrials.gov/show/nct00282009	1
1173	camaguey:171:2009	1
1174	4009	1
1175	1.383-3.109	1
1176	0/109	1
1177	//www.clinicaltrials.gov/ct2/show/nct01236209	2
1178	2951-6609	1
1179	cam:171:09	1
1180	1.22-2.19	1
1181	1.28-6.19	1
1182	1.06-37.19	1
1183	8/119	3
1184	143/419	1
1185	//clinicaltrials.gov/ct2/show/nct01114919	1
1186	0:58-1:19	1
1187	b2→b19	3
1188	2012-003343-29	1
1189	0.09-0.29	2
1190	rr=0.29	1
1191	1.06-1.29	1
1192	1.09-1.29	1
1193	3.88-9.29	1
1194	31/29	3
1195	23/129	1
1196	16/129	1
1197	370/429	1
1198	//www.controlled-trials.com/isrctn57754429	1
1199	nct00049829	1
1200	f29	1
1201	3·28-9·29	1
1202	es=0.39	1
1203	1.01-2.39	1
1204	1.53-2.39	2
1205	0.98-3.39	1
1206	1/39	3
1207	22/39	5
1208	3/39	9
1209	4/39	6
1210	19/39	5
1211	//isrctn80067039	1
1212	1·139	1
1213	isrctn46295339	1
1214	//www.clinicaltrials.gov/ct2/show/nct00158639	1
1215	//www.controlled-trials.com/isrctn35739639	2
1216	1.01-2.49	2
1217	-14.49	1
1218	nct00497549	1
1219	//www.clinicaltrials.gov/ct2/show/nct01715649	1
1220	a=8.4749	1
1221	nct00667849	2
1222	0.84-1.59	1
1223	1.25-1.59	1
1224	1.76-24.59	1
1225	0.30-5.59	1
1226	1.01-3.059	1
1227	115/159	1
1228	0.080-0.859	1
1229	08:00-15:59	1
1230	m3o-bc59	5
1231	.31-.69	1
1232	1.29-1.69	1
1233	1.02-2.69	1
1234	0.42-2.69	1
1235	113.69	1
1236	5/69	2
1237	29/69	3
1238	isrctn61861069	1
1239	25-169	1
1240	55/169	1
1241	106369	1
1242	nct01774669	1
1243	-2·69	1
1244	0.17-0.79	1
1245	561.79	1
1246	1.43-2.79	1
1247	1.09-3.79	1
1248	-0.84+/-6.79	1
1249	1.88-6.79	1
1250	0.070-0.079	2
1251	//clinicaltrials.gov/show/nct01340079	1
1252	167/279	1
1253	21,779	1
1254	4.779	1
1255	0.614-0.979	1
1256	1.28-4.89	1
1257	4/89	5
1258	34/89	1
1259	drks00003589	1
1260	//clinicaltrials.gov/ct2/show/nct01469689	2
1261	132/989	1
1262	11,99	1
1263	0.38-0.99	1
1264	0.09-0.99	2
1265	1.95-7.99	1
1266	nct01802099	1
1267	1·099	1
1268	nct00473499	1
1269	0.0899	1
1270	//clinicaltrials.gov/show/nct00873899	1
1271	iief-q9	4
1272	0·5-2·9	1
1273	0·8-2·9	1
1274	opp=	1
1275	test-a	18
1276	sm1a	3
1277	do3a	4
1278	lo-asca	1
1279	3,4-dhpea-eda	3
1280	lialda	2
1281	chilopoda	2
1282	/pa-ea	1
1283	high-sfa	10
1284	large-for-ga	1
1285	lmw-ha	4
1286	top2alpha	1
1287	edronax-pharmacia	1
1288	asistencia	1
1289	bronchitis/pneumonia/bronchopneumonia	1
1290	anti-diphteria	1
1291	tvie/tvia	1
1292	wattakaka	1
1293	roelfsema	1
1294	0ima	1
1295	uprima	2
1296	intermontana	1
1297	euphyodesmusphilippina	1
1298	ant-moa	2
1299	48.2kpa	1
1300	93.4kpa	1
1301	sanjappa	1
1302	bospa	1
1303	dermaptera	2
1304	la/sa	3
1305	hba2-yialousa	1
1306	h2-bibta	2
1307	mehta	2
1308	hexahydro-2a,4a,6a-triaza-6b-phosphacyclopenta	1
1309	evista	10
1310	3xsta	2
1311	gve/gva	2
1312	courneya	3
1313	zolinza	4
1314	gstp1*b	1
1315	test-b	12
1316	alpha-bab	3
1317	docetaxel+oxaliplatin+cetuximab	1
1318	protoaphin-fb	1
1319	deltandhb	1
1320	xtb	5
1321	tvb	3
1322	2',3'-c	1
1323	ma-c	2
1324	neisvac-c	4
1325	ce-c	2
1326	p-c	12
1327	t-c	37
1328	cfu-c	4
1329	c.1670-191c	1
1330	514c	1
1331	m184c	1
1332	l126c	1
1333	n=c	3
1334	nolac	3
1335	αlac	4
1336	cormac	1
1337	non-abc	3
1338	rebec	16
1339	ta-nic	1
1340	akinetic-dyskinetic	1
1341	milosevic	1
1342	malkjovic	1
1343	gr-dlc	1
1344	jmc	1
1345	20°c/20°c	1
1346	36.35°c	1
1347	laminaria-d	1
1348	nc-d	2
1349	7-eth-d	3
1350	znp-s-pcbd	1
1351	tacd	3
1352	self-moulded	2
1353	met35red	2
1354	normal/increased	1
1355	alcohol/drug-revised	1
1356	kbagd	4
1357	severity-adhd	1
1358	duofluorid	1
1359	1.49-fold	2
1360	gdsand	5
1361	qbblind	1
1362	wasmund	1
1363	poor-good	1
1364	hdpd	4
1365	nygaard	1
1366	ventriguard	2
1367	brainerd	1
1368	whitford	1
1369	birrd	1
1370	cisd	8
1371	massoud	1
1372	nonhdl-e	2
1373	gmfcs-e	5
1374	y=0.21e	1
1375	y=0.15e	1
1376	cichlidae	3
1377	scolytinae	2
1378	deltae	11
1379	moderate-resistance-moderate-endurance	1
1380	xce	1
1381	yce	2
1382	claparede	1
1383	a=fluorouracil-epirubicin-cyclophosphamide	1
1384	cobamamide	4
1385	2'-o-acetyldihydropenstemide	1
1386	galacto-oligosaccharide/fructo-oligosaccharide	1
1387	myricetin-3-o-arabinopyranoside	1
1388	simde	8
1389	adp-fe	1
1390	0.396*age	1
1391	corbridge	1
1392	jingbie	1
1393	mcconkie	1
1394	diarylpropionitrile	4
1395	chlorhexidine-metronidazole	1
1396	2.ae+prime	1
1397	etch+prime	1
1398	steane	1
1399	diane	7
1400	1,2-butadiene	1
1401	,14,16-triene	1
1402	2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine	3
1403	3'-c-ethynylcytidine	1
1404	sham+saline	1
1405	butorphanol/saline	1
1406	d9-phosphatidylcholine	1
1407	diolylphosphatidylethanolamine	1
1408	n-stearoylethanolamine	1
1409	een+glutamine	1
1410	-arginine	7
1411	-cycloserine	1
1412	millaurine	1
1413	dihydro-artemisinin-piperaquine	1
1414	azetidin-2-one	2
1415	dione	7
1416	4-phenyl-1,2,4-triazole-3,5-dione	1
1417	androsteredione	1
1418	m=methylprednisolone	1
1419	sistostenone	1
1420	5,6,4'-trihydroxy-7,8-dimethoxyflavone	1
1421	sensodyne	24
1422	dichelyne	2
1423	sappanin-type	1
1424	goodacre	1
1425	cr-before	1
1426	g-pre	1
1427	ditre	1
1428	postbrochure	2
1429	hemagglutinin-neuraminidase	6
1430	n-acetylglucosaminidase	2
1431	cholesterol-0-acyltransferase	1
1432	polypeptide-o-beta-acetylglucosaminyltransferase	1
1433	ubiquinone-oxidoreductase	1
1434	cdsmp-plus-exercise	1
1435	mnse	3
1436	trimethacrylate	3
1437	polymethoxyethylacrylate	1
1438	octyl-p-methoxycinnamate	1
1439	polystyrenesulfonate	1
1440	-aspartate	2
1441	caucasian/white	3
1442	pck-technique	1
1443	lallave	1
1444	a-hypertensive	1
1445	pd-negative	5
1446	iib-positive	1
1447	mcpyv-positive	1
1448	portionsize	2
1449	lemée	1
1450	f	6,657
1451	moderate-f	1
1452	522/f	1
1453	hexanic-leaf	2
1454	/df	1
1455	pcdf	7
1456	δiief-ef	1
1457	mef	74
1458	drcf-dwarf	1
1459	c-g-g	2
1460	642g	1
1461	c.82g	2
1462	a49g	1
1463	rv-rag	3
1464	116.14ngg	1
1465	203.54ngg	1
1466	0.02-16.34microgg	1
1467	jjg	1
1468	crs/kg	5
1469	64.2±6.5mlkg	1
1470	cd40lg	4
1471	c.139delg	1
1472	tae-yang	3
1473	soyang	3
1474	i-ing	1
1475	spotting/bleeding	1
1476	spirit-calling	1
1477	downtraining	1
1478	sand-blasting	1
1479	a-receiving	1
1480	exposure_long	1
1481	minicog	1
1482	-log	5
1483	hyper-tg	1
1484	stimtg	9
1485	drug/drug	5
1486	pdrug	3
1487	∆g	9
1488	δg	62
1489	life-h	5
1490	qlq-h	8
1491	pss-h	2
1492	fact-h	6
1493	mhlw-h	2
1494	3.2h	3
1495	wca6h	5
1496	scch	1
1497	bausch	43
1498	3'-igh	3
1499	eyewash	3
1500	3.42/month	1
1501	2.25/month	1
1502	wth	14
1503	blyth	1
1504	rad-i	1
1505	rg-i	2
1506	v90i	3
1507	aiai	1
1508	deci	4
1509	plavix-sanofi	1
1510	mi/mii	1
1511	amalaki	4
1512	bibhitaki	3
1513	haritaki	6
1514	lsli	2
1515	xami	3
1516	naemi	1
1517	behbehani	1
1518	des-31,32-pi	3
1519	normal-pi	1
1520	consort-spi	4
1521	canestri	1
1522	ipdasi	6
1523	classi	1
1524	-au/rusi	1
1525	go-au/rusi	2
1526	spti	21
1527	ao-vti	2
1528	janssen/j	1
1529	fj	50
1530	j/k	3
1531	trak	9
1532	olineck	1
1533	crasilneck	1
1534	vlok	1
1535	baumstark	1
1536	bazyluk	3
1537	nuk	1
1538	lv-sd12-l	3
1539	24.6pmol/l	1
1540	41.594l	1
1541	asgaal	2
1542	naal	2
1543	biological/physical	1
1544	ovary/peritoneal	1
1545	lactateinitial	2
1546	goodman-kruskal	2
1547	imal	3
1548	cellulosomal	2
1549	circumferential-longitudinal	4
1550	isosurvival	9
1551	3cl	24
1552	ych3nh3cl	1
1553	agcl	5
1554	mocl	2
1555	kibel	1
1556	oxa-gel	2
1557	regel	9
1558	pronamel	14
1559	2-megapixel	1
1560	patgl=docgl	2
1561	lgi-lgl	3
1562	garaigordobil	1
1563	mollosil	7
1564	zentall	1
1565	k.d.hill	1
1566	nevill	1
1567	4.6±4.4pmoll	1
1568	5u/ml	1
1569	2625ml	1
1570	0.50-2.58μghml	1
1571	//www.bcshguidelines.com/bcsh_process/evidence_levels_and_grades_of_recommendation/43_grade.html	1
1572	triazole-3-thiol	1
1573	prepropranolol	1
1574	nonadecanol	1
1575	hydroxy-α-sanshool	4
1576	clinic-control	2
1577	i-control	1
1578	ct-control	2
1579	early-control	1
1580	plasmacontrol	1
1581	2-o-methyl-l-chiro-inositol	1
1582	∆ppl	2
1583	windschitl	1
1584	//tkm.kiom.re.kr/ontology/traditionalkoreanmedicine.rdf-xml.owl	1
1585	yl	7
1586	h-pyrazol-1-yl	1
1587	diphenylmethyl	4
1588	ethyl-sulfanyl	2
1589	ethylsulfanyl	2
1590	ferrocenyl	5
1591	sulfinyl	6
1592	carbamoyl	13
1593	phosphinoyl	5
1594	tosyl	2
1595	pentyl	6
1596	36.3±5.4kg/m	1
1597	bmi=27-45kg/m	1
1598	21.9±1.7kg/m	1
1599	50-89mg/m	1
1600	c10m	3
1601	etch-and-rinse/rubber-dam	1
1602	qam	11
1603	paroxetine-escitalopram	1
1604	c/cm	2
1605	dyne/cm	6
1606	112.5j/cm	1
1607	0.2w/cm	1
1608	180.02gycm	1
1609	126.64gycm	1
1610	53.66gycm	1
1611	g-cem	9
1612	extem	8
1613	trfm	2
1614	mim	46
1615	372/mm	1
1616	469/mm	1
1617	cysts/mm	2
1618	-0.4mm	1
1619	-26.5mm	1
1620	-8mm	1
1621	//www.gsk-clinicalstudyregister.com	1
1622	//www.gsk-clinicalstudywww.gsk-clinicalstudyregister.com	1
1623	pglom	2
1624	/pom	1
1625	evpm	4
1626	essm	9
1627	yb/tm	2
1628	hotm	4
1629	taeum	2
1630	sarocladium	1
1631	honorarium	7
1632	bivm	2
1633	acr-n	7
1634	2n	45
1635	sc3n	10
1636	n-bu4n	3
1637	s125n	1
1638	cahsp25.99n	1
1639	bu-phoban	2
1640	≤median	2
1641	kahneman	2
1642	tillman	1
1643	amerman	1
1644	szechtman	1
1645	8,8'dimethyl-3,4,3',4'-dimethylenedioxy-7-oxo-2,7'cyclolignan	1
1646	micen	2
1647	neupogen	14
1648	mikrogen	2
1649	mychen	1
1650	salen	8
1651	lehtinen	3
1652	humapen	9
1653	qbopen	1
1654	kellegren	1
1655	litten	2
1656	7-lsign	1
1657	rv-strain	3
1658	palmolein	2
1659	myrtillin	2
1660	3'-o-methyltaxifolin	1
1661	0.685min	1
1662	lavmin	2
1663	oregonin	1
1664	1,3-dimethylol-5,5-dimethylhydantoin	1
1665	docetaxel+oxaliplatin	1
1666	variotin	1
1667	ln	742
1668	lys751gln	2
1669	arg339gln	1
1670	jmn–mn	4
1671	altmann	1
1672	amidon	1
1673	condylion-pogonion	1
1674	text-comprehension	1
1675	null-mutation	1
1676	a.nelson	1
1677	cordis/johnson	1
1678	monson	1
1679	kapson	1
1680	arnarson	1
1681	gonion-menton	1
1682	gaston	1
1683	bendall-lyon	1
1684	tn-tn-tn	1
1685	satogun	1
1686	lta/vn	1
1687	17syn	3
1688	zno/zn	1
1689	δn	5
1690	5a-5o	1
1691	aldao	1
1692	ca4lao	1
1693	ptb-bo	2
1694	plavix-sanofi-synthelabo	1
1695	control-placebo	3
1696	no-lsm-placebo	1
1697	n-placebo	1
1698	dehydration-placebo	1
1699	younger-placebo	1
1700	sedentary-placebo	2
1701	placebo/placebo	13
1702	gbp/placebo	1
1703	c4h3o-cho	1
1704	c6h5cho	3
1705	quinazolin-4-ylthio	2
1706	in-labeled-spio	1
1707	ptio	4
1708	hepta-cyclo	1
1709	12,30-di-aza-hepta-cyclo	1
1710	3,4-dimethyl-5,5-dioxidopyrazolo	2
1711	-no	15
1712	mmancano	1
1713	gaudiano	1
1714	cusimano	6
1715	aunano	1
1716	clno	4
1717	coo	38
1718	saramuro	5
1719	baso	3
1720	chapso	5
1721	chamisso	1
1722	shigyaku-to	2
1723	kamiuntanto	1
1724	desenvolvimento	1
1725	proto	6
1726	gdvo	1
1727	yvo	3
1728	pizzo	1
1729	yca₄o	2
1730	g10-p	1
1731	g8-p	1
1732	csf-p	11
1733	lns-p	4
1734	g3p	28
1735	0.4p	1
1736	g6p	5
1737	p=p	1
1738	dmap	9
1739	rpap	6
1740	placebo/gbp	1
1741	9.lvedp	1
1742	extrastep	5
1743	simplestep	4
1744	kt-cfp	3
1745	:egfp	1
1746	tadip	1
1747	-pnkp	1
1748	phosphoaspartyl-pnkp	1
1749	smz/tmp	3
1750	pre-op	37
1751	18hcrp	1
1752	lncrp	2
1753	si-prp	5
1754	gr-prp	2
1755	pglu-leu-asn-phe-ser-pro-gly-trp	1
1756	rvesp	11
1757	g.44369_50449dup	1
1758	buckup	1
1759	11.mpcwp	1
1760	1+exp	5
1761	thiq	5
1762	psg/r	2
1763	yellow-poplar	1
1764	ni-sar	3
1765	qvar	13
1766	alwar	1
1767	n⋯br	2
1768	bmd-dr	4
1769	liquid/powder	1
1770	hager	1
1771	self-anger	1
1772	deffenbacher	1
1773	beier	1
1774	gauthier	2
1775	bonnier	1
1776	egner	1
1777	figner	1
1778	hepper	1
1779	meiser	3
1780	rifater	2
1781	3pter	1
1782	:beta-glucuronidase-reporter	1
1783	quartermaster	2
1784	phenyl-c61-butyric-acid-methylester	1
1785	greuter	4
1786	mdfr	5
1787	auc0-12hr	3
1788	denzir	3
1789	intensive/indoor	1
1790	g1-excavator	1
1791	-factor	2
1792	durafluor	1
1793	tr/pr	4
1794	37±15hour	1
1795	alvr	5
1796	δr	23
1797	eco-s	2
1798	rvfw-s	3
1799	6.75m/s	1
1800	-0.94±0.30s	1
1801	-1.94±0.30s	1
1802	-1.74±0.31s	1
1803	ilc1s	1
1804	-0.98±0.23s	1
1805	-1.00±0.24s	1
1806	-1.97±0.26s	1
1807	-0.98±0.26s	1
1808	-1.93±0.29s	1
1809	mcdas	3
1810	libbs	1
1811	insbs	2
1812	pharmacometrics	5
1813	δigf-1sds	2
1814	medtronic-electrodes	1
1815	hales	1
1816	enterobacteriales	3
1817	flavanes	2
1818	cendres	1
1819	elutes	11
1820	boyes	1
1821	adolphs	1
1822	2.4months	1
1823	4-amino-2,2-bis	1
1824	sulfinylbis	2
1825	valois	2
1826	trois	3
1827	immunofortis	5
1828	ntrtis	4
1829	breadsticks	3
1830	obstetricans	1
1831	erkens	1
1832	sens	11
1833	starns	1
1834	vos	3
1835	⩾75years	1
1836	schoenmakers	1
1837	ethyl-esters	4
1838	olivers	1
1839	rvsrs	3
1840	rt7ss	4
1841	in-process	213
1842	redness/greenness	2
1843	fiss	2
1844	postcard/letter/pamphlets	1
1845	osa/mets	1
1846	41patients	1
1847	α-agonists	1
1848	vbus	11
1849	coleus	11
1850	diškus	3
1851	subcontinuous	1
1852	dnad-devd-t	1
1853	post-t	1
1854	c-bat	3
1855	-intention-to-treat	2
1856	control-fat	1
1857	smlat	1
1858	kinact	3
1859	yodt	1
1860	perruchet	1
1861	11,12-dhet	1
1862	phet	24
1863	a-diet	1
1864	yttrium-scandium-gallium-garnet	6
1865	yttrium–aluminum–garnet	1
1866	sevoflurane-lidocaine-tourniquet	1
1867	forward-left	1
1868	hcnt	3
1869	sitagliptin-treatment	1
1870	3-substituent	2
1871	diaroot	1
1872	rhinocort	2
1873	exposure_short	1
1874	toegepast	1
1875	sbst	7
1876	hewitt	5
1877	δgwt	1
1878	δ6mwt	6
1879	wt×wt	1
1880	-1.59u	1
1881	pedop-au	3
1882	bi-arg/au	3
1883	cassagnau	3
1884	neu	47
1885	xeu	13
1886	vmu	5
1887	hfnu	9
1888	c.y.wu	2
1889	0.253v	1
1890	0.348v	1
1891	∆lvedv	2
1892	pre-fev	1
1893	ofirmev	3
1894	jmv	3
1895	ph-ponv	10
1896	//clinicaltrails.gov	1
1897	zhdanov	1
1898	inferior/+rv	1
1899	m/w	2
1900	ngt/low	1
1901	e-flow	1
1902	1.024x	1
1903	λmax	26
1904	pax	10
1905	wall-motion-score-index	1
1906	cold-fx	1
1907	vectibix	3
1908	fluarix	6
1909	zyvox	2
1910	dpcpx	9
1911	//www.anzctr.org.au/actrn12610000135011.aspx	1
1912	//www.anzctr.org.au/actrn12609000819224.aspx	1
1913	//www.anzctr.org.au/actrn12608000411347.aspx	1
1914	33μg/kg/day	1
1915	tdelay	3
1916	xdy	6
1917	80gy	2
1918	ganzfeld-electroretinography	1
1919	kashy	1
1920	orlinsky	1
1921	dly	4
1922	todaearly	1
1923	ultraminilaparotomy	1
1924	g-jstomy	4
1925	quoy	1
1926	foam-sclerotherapy	2
1927	ground-glass-opacity	1
1928	anhedonia-asociality	3
1929	hemodynamic-obesity	1
1930	agassiz	1
1931	dalz	2
1932	benz	12
1933	2ehrz	3
1934	isaacowitz	1
1935	dxz	5
1936	dyz	3
1937	\|	27
1938	t₀	12
1939	₅₀	4
1940	π	133
1941	/π	1
1942	2π	1
1943	4/3π	2
1944	f₂	10
1945	n→σ	1
1946	cofe₂o₄	5
1947	-fe₃o₄	1
1948	ndpa-fe₃o₄	8
1949	algna/fe₃o₄	1
1950	τ	307
1951	hυ	1
1952	∆	58
1953	φ	66
1954	̇	2
1955	ψ	19
1956	∆ψ	3
1957	ω	141
1958	i13/2→	2
1959	f5/2→	2
1960	0.781×	1
1961	anaconda®	1
1962	improvac®	4
1963	papacárie®	2
1964	osteobiol®	2
1965	epivir®	1
1966	≥67.0°	1
1967	+4.1°	1
1968	+2.2°	1
1969	+1.4°	1
1970	+0.6°	1
1971	+2.6°	2
1972	ibα	5
1973	hif-1β	3
1974	sβ	6
1975	3'ψβ	2
1976	pγ	1
1977	δ	1,115
1978	n¹	3
1979	barû	1
1980	-\|ν	1